Document:

EX-10.11

 CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY [****], HAS BEEN OMITTED BECAUSE IT
IS BOTH (I) NOT MATERIAL AND (II) WOULD BE COMPETITIVELY HARMFUL IF PUBLICLY DISCLOSED. 
 Exhibit 10.11 

CONFIDENTIAL – EXECUTION VERSION 
  

 
 MANUFACTURING SERVICES AGREEMENT 

between 
 JABIL INC.,

 and 
 LUCIRA
HEALTH INC. 

 INDEX 
  

											
	 1.
	 	Definitions	  	 	1	 
			
	 2.
	 	List of Schedules	  	 	5	 
			
	 3.
	 	Forecasts	  	 	5	 
				
		 	3.1	 	Forecast Generation and Master Scheduling	  	 	5	 
				
		 	3.2.	 	Master Scheduling	  	 	6	 
				
		 	3.3.	 	Forecast Rescheduling	  	 	6	 
			
	 4.
	 	Manufacturing Services	  	 	6	 
				
		 	4.1.	 	Jabil’s General Obligations	  	 	6	 
				
		 	4.2.	 	Consigned Equipment	  	 	6	 
					
		 		 	 4.2.1.
	 	 General Items to be Supplied by Company
	  	 	6	 
					
		 		 	 4.2.2.
	 	 Molding and Automation Equipment; Maintenance
	  	 	6	 
				
		 	4.3.	 	Company Inspection	  	 	7	 
				
		 	4.4.	 	Materials Procurement	  	 	7	 
				
		 	4.5.	 	Materials Declaration	  	 	7	 
				
		 	4.6.	 	Product Evaluation	  	 	7	 
					
		 		 	 4.6.1.
	 	 Initial Inspection
	  	 	7	 
					
		 		 	 4.6.2.
	 	 Disputed Rejection
	  	 	8	 
			
	 5.
	 	Warranty & Remedy	  	 	8	 
				
		 	5.1.	 	Jabil Warranty	  	 	8	 
				
		 	5.2.	 	Repair or Replacement of Defective Product	  	 	8	 
				
		 	5.3.	 	Limitation of Warranty	  	 	8	 
				
		 	5.4.	 	Debarment	  	 	9	 
			
	 6.
	 	Limitation of Damages	  	 	9	 
			
	 7.
	 	Delivery and Financial Terms	  	 	9	 
				
		 	7.1.	 	Delivery and Pricing	  	 	9	 
					
		 		 	 7.1.1.
	 	 Delivery
	  	 	9	 
					
		 		 	 7.1.2.
	 	 Pricing
	  	 	10	 
					
		 		 	 7.1.3.
	 	 Export Declaration
	  	 	10	 
					
		 		 	 7.1.4.
	 	 Price Changes
	  	 	10	 
				
		 	7.2.	 	Payment	  	 	11	 
				
		 	7.3.	 	NRE	  	 	11	 
				
		 	7.4.	 	Taxes	  	 	11	 
				
		 	7.5.	 	Foreign Currency	  	 	11	 
				
		 	7.6.	 	Aggregate Credit Limit	  	 	11	 

  
 i 

											
	 8.
	 	 Import and Export; Quality and Regulatory Obligations; FAR Regulations
	  	 	12	 
				
		 	 8.1.
	 	Import and Export	  	 	11	 
				
		 	 8.2.
	 	Quality and Regulatory Obligations	  	 	11	 
					
		 		 	 8.2.1.
	  	 Quality Agreement
	  	 	12	 
					
		 		 	 8.2.2.
	  	 Regulatory Activities; Information
	  	 	12	 
					
		 		 	 8.2.3.
	  	 Mandated Changes to Specifications and Manufacturing Process
	  	 	12	 
					
		 		 	 8.2.4.
	  	 Records
	  	 	13	 
					
		 		 	 8.2.5.
	  	 Complaints
	  	 	13	 
					
		 		 	 8.2.6.
	  	 Recalls
	  	 	13	 
					
		 		 	 8.2.7.
	  	 Regulatory Actions
	  	 	13	 
				
		 	 8.3.
	 	Design Services; US Government Contracts	  	 	14	 
			
	 9.
	 	 Change Orders, Production Increases; Forecast Flexibility
	  	 	14	 
				
		 	 9.1.
	 	Specification, Product or Process Changes	  	 	14	 
				
		 	 9.2.
	 	Forecast/PO Flexibility	  	 	14	 
					
		 		 	 9.2.1.
	  	 Reschedules and Cancellations
	  	 	14	 
					
		 		 	 9.2.2.
	  	 Production Increases
	  	 	14	 
				
		 	 9.3.
	 	Safety Stock	  	 	15	 
				
		 	 9.4.
	 	Excess Material and Obsolete Material	  	 	15	 
				
		 	 9.5.
	 	End of Life Material	  	 	15	 
			
	 10.
	 	 Term
	  	 	15	 
			
	 11.
	 	 Termination and Termination Charges
	  	 	16	 
				
		 	 11.1.
	 	Termination Rights	  	 	16	 
				
		 	 11.2.
	 	Reserved	  	 	16	 
				
		 	 11.3.
	 	Termination for Cause	  	 	16	 
				
		 	 11.4.
	 	Termination for Bankruptcy/Insolvency	  	 	16	 
				
		 	 11.5.
	 	Termination Effects	  	 	16	 
				
		 	 11.6.
	 	Duty to Mitigate Costs	  	 	17	 
			
	 12.
	 	 Confidentiality
	  	 	17	 
				
		 	 12.1.
	 	Confidentiality Obligations	  	 	17	 
				
		 	 12.3.
	 	Employees, Agents and Representatives	  	 	18	 
				
		 	 12.4.
	 	Term and Enforcement	  	 	18	 
				
		 	 12.5.
	 	Return of Proprietary Information and Technology	  	 	18	 
			
	 13.
	 	 Intellectual Property Rights
	  	 	18	 
				
		 	 13.1.
	 	Intellectual Property Ownership	  	 	18	 
				
		 	 13.2.
	 	Company Intellectual Property	  	 	18	 
			
	 14.
	 	 Company Indemnification
	  	 	19	 

  
 ii 

									
		 	14.1.	  	Jabil Indemnified Claims	  	 	19	 
				
		 	14.2.	  	Company Indemnified Claims	  	 	19	 
				
		 	14.3.	  	Control of Defense	  	 	19	 
			
	 15.
	 	 Relationship of Parties
	  	 	19	 
			
	 16.
	 	 Insurance
	  	 	19	 
			
	 17.
	 	 Publicity
	  	 	20	 
			
	 18.
	 	 Force Majeure
	  	 	20	 
			
	 19.
	 	 Miscellaneous
	  	 	20	 
				
		 	19.1.	  	Notices	  	 	20	 
				
		 	19.2.	  	Amendment	  	 	20	 
				
		 	19.3.	  	Partial Invalidity	  	 	21	 
				
		 	19.4.	  	Anti-Bribery Laws	  	 	21	 
				
		 	19.5.	  	Entire Agreement	  	 	21	 
				
		 	19.6.	  	Assignment	  	 	21	 
				
		 	19.7.	  	Waiver	  	 	21	 
				
		 	19.8.	  	Captions and Section References	  	 	21	 
				
		 	19.9.	  	Construction	  	 	21	 
				
		 	19.10.	  	Dispute Resolution	  	 	21	 
				
		 	19.11.	  	Other Documents	  	 	22	 
				
		 	19.12.	  	Counterparts	  	 	22	 
				
		 	19.13.	  	Governing Law and Jurisdiction	  	 	22	 

  
 iii 

 MANUFACTURING SERVICES AGREEMENT 

This Manufacturing Service Agreement (“Agreement”) is entered into as of September 10th, 2020 (“Effective Date”) by and between Jabil Inc., having its principal place of business at 10560 Dr. M.L. King Jr. Street North St. Petersburg, Florida 33716, on behalf of
itself and its affiliates (“Jabil”), and Lucira Health, Inc. a Delaware corporation, (“Company”). Jabil and Company are referred to herein individually as “Party”, or collectively as “Parties”. 

RECITALS 
 A. WHEREAS,
Jabil is in the business of designing, developing, manufacturing, testing, configuring, assembling, packaging and shipping electronic assemblies and systems. 

B. WHEREAS, Company is in the business of designing, developing, distributing, marketing and selling products containing electronic assemblies
and systems. 
 C. WHEREAS, on or about the Effective Date, the Parties shall enter into a Technical Services Agreement, dated September
10th, 2020 (the “TSA”) pursuant to which the Company will engage Jabil to perform certain technical services in relation to the Company’s product. 

D. WHEREAS, the Parties desire that Jabil manufacture, test, configure, assemble, package and/or ship certain electronic assemblies and
systems pursuant to the terms and conditions set forth in this Agreement. 
 NOW, THEREFORE, in consideration of the foregoing and
the mutual covenants contained herein, and other good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged, the Parties agree as follows: 

TERMS 
 1.
Definitions. In addition to terms defined elsewhere in this Agreement, the capitalized terms set forth below shall have the following meaning: 
  

			
	 “AAA”
	  	shall have the meaning set forth in Section 19.10.
		
	 “Affiliate”
	  	means with respect to a Person, any other Person which directly or indirectly controls, or is controlled by, or is under common control with such Person. For purposes of the preceding sentence, “control” of a Person
shall mean the possession, directly or indirectly, of the power to direct or cause the direction of the management or policies of such Person, or direct or indirect ownership (beneficially or of record) of, or direct or indirect power to vote, 50%
or more of the outstanding shares of any class of capital stock of such Person (or in the case of a Person that is not a corporation, 50% or more of any class of equity interest).
		
	 “Aggregate Credit Limit”
	  	Shall have the meaning set forth in Section 7.6.
		
	 “Automation”
	  	shall have the meaning set forth in Section 4.2.2
		
	 “Business Day”
	  	means Monday through Friday, except for federal, state or bank holidays where the Manufacturing Service is provided.

  
 Page 1 

			
	 “Background Intellectual Property”
	  	means any Intellectual Property owned, or controlled by a Party (a) prior to the Effective Date, or (b) developed or acquired after the Effective Date of this Agreement and independent of this Agreement without the use
of other Party’s Proprietary Information and Technology.
		
	 “Bailed Equipment”
	  	shall have the meaning set forth in Section 4.2.2
		
	 “cGMP”
	  	means the current good manufacturing practice regulations promulgated, administered and enforced by the FDA as set forth in 21 C.F.R. Part 820 or other similar and applicable regulatory requirements applicable to the manufacture
and supply of a Product.
		
	 “Claims”
	  	shall have the meaning set forth in Section 14.1
		
	 “Commercially Reasonable Efforts”
	  	means with respect to a given Person and a given activity or objective, the reasonable efforts and resources to accomplish such objective or activity that would be comparable with the efforts and resources commonly used in the
manufacturing and biotechnology industry by a commercial entity of similar size in respect of personnel and financial resources as the applicable Person, expended in a manner and timing consistent with the exercise of prudent business judgment
[****].
		
	 “Company Indemnitees”
	  	shall have the meaning set forth in Section 14.2
		
	 “Company Liability”
	  	shall have the meaning set forth in Section 9.4.
		
	 “Components”
	  	means those components, parts or materials to be incorporated into the Product, including spares and subassemblies, that Company either provides, directly or indirectly, to Jabil or are purchased through component suppliers
designated, specified and/or approved by Company.
		
	 “Proprietary Information and Technology”
	  	means, without limitation, software, firmware, hardware, technology and know-how and other proprietary information or intellectual property embodied therein that is known, owned or licensed
by and proprietary to either Party and not generally available to the public, including plans, analyses, trade secrets, patent rights, copyrights, trademarks, inventions, fees and pricing information, operating procedures, procedure manuals,
processes, methods, computer applications, programs and designs, and any processed or collected data. The failure to label any of the foregoing as “confidential” or “proprietary” shall not mean it is not Proprietary Information
and Technology.
		
	 “Defect” or “Defective”
	  	shall have the meaning set forth in Section 5.2.
		
	 “EOL”
	  	shall have the meaning set forth in Section 9.5.
		
	 “Evaluation Period”
	  	shall have the meaning set forth in Section 4.6.

  
 Page 2 

			
	 “Excess Material”
	  	means Components, WIP or Products on hand or on order by Jabil for more than [****] and which were ordered, purchased or manufactured based on a MOQ, Forecast or Purchase Orders or other written instruction by Company to
Jabil.
		
	 “Exit Plan”
	  	shall have the meaning set forth in Section 11.7.
		
	 “FDA”
	  	means the United States Food and Drug Administration
		
	 “Firm Period”
	  	shall have the meaning set forth in Section 9.2.1
		
	 “Forecast”
	  	shall have the meaning set forth in Section 3.1.
		
	 “Indemnifying Party”
	  	shall have the meaning set forth in Section 14.3
		
	 “Intellectual Property”
	  	shall mean patents, design(s) (whether or not capable of registration), chip topography right(s), database rights and other like protection, copyright(s), trademark(s), trade names(s), trade dress(es), trade secrets and/or any other
industrial and/or intellectual property right(s) and applications, divisions, continuations, renewals, re-exams and reissues therefore and any discoveries, inventions, technical information, procedures or
processes software, firmware, technology, know-how.
		
	 “Jabil Indemnitees”
	  	shall have the meaning set forth in Section 14.1
		
	 “Lead-time”
	  	Means the minimum amount of time for Jabil to procure and receive necessary Components plus the time needed to manufacture, test and ship the Product from Jabil’s facility.
		
	 “Loaned Equipment”
	  	means capital equipment (including tools) which is loaned to Jabil by or on behalf of Company (or procured by Jabil on behalf of Company) to be used by Jabil to perform the Manufacturing Services and includes all equipment, tools
and fixtures purchased specifically for Company, by Jabil, to perform the Manufacturing Services and that are paid for in full by Company.
		
	 “Losses”
	  	shall have the meaning set forth in Section 14.1
		
	 “Manufacturing Services”
	  	means the services performed by Jabil hereunder which shall include but not be limited to manufacturing, testing, configuring, assembling, packaging and/or shipping of the Product, including any additional services, all in
accordance with the Specifications.
		
	 “Material Inventory”
	  	shall have the meaning set forth in Section 9.4.
		
	 “Materials Declaration Requirements”
	  	means any requirements, obligations, standards, duties or responsibilities pursuant to any environmental, product composition, ecodesign (Directive 2009/125/EC), energy use, energy efficiency and/or materials declaration laws,
directives, or regulations, including international laws and treaties regarding such subject matter; and any regulations, interpretive guidance or enforcement policies related to any of the foregoing.
		
	 “Molds”
	  	shall have the meaning set forth in Section 4.2.2

  
 Page 3 

			
	 “Molding Equipment”
	  	shall have the meaning set forth in Section 4.2.2
		
	 “MOQ” or “Minimum Order Quantity”
	  	means Components purchased in excess of Forecast requirements from POs or Forecast, because of the minimum lot sizes required by the suppliers supplying Components to support the pricing provided to Company by Jabil.
		
	 “MPS”
	  	shall have the meaning set forth in Section 3.2.
		
	 “Notice of Disputed Defect”
	  	shall have the meaning set forth in Section 4.6.
		
	 “NRE Costs”
	  	shall consist of expenses incurred by Jabil under this Agreement, including design engineering services, testing, fixturing and tooling and other
out-of-pocket costs, in each case solely to the extent directly allocable to the manufacture and supply of Product
		
	 “Obsolete Material”
	  	means Components that no longer appear on a bill of material or Component, WIP, or Products that has no demand or usage for at least [****] and which were ordered, purchased or manufactured based on a Forecast, MOQs or Purchase
Orders or other written instruction by Company to Jabil.
		
	 “Person”
	  	means any corporation, business entity, natural person, firm, joint venture, limited or general partnership, limited liability entity, limited liability partnership, trust, unincorporated organization, association, government, or
any department or agency of any government.
		
	 “Product(s)”
	  	means the product(s) manufactured and assembled by Jabil on behalf of Company under this Agreement as identified in Schedule 1 (or any subsequent Schedule 1 prepared for any product to be manufactured hereunder) including any
updates, renewals, modifications or amendments thereto.
		
	 “Pricing Period”
	  	means the [****] (or any other period mutually agreed upon) commencing on the first day of the next calendar month after the Effective Date, and each [****] (or any other period mutually agreed upon) thereafter.
		
	 “Product Warranty”
	  	Shall have the meaning set forth in Section 5.1.
		
	 “Purchase Order” or “PO”
	  	means a firm purchase order provided to Jabil by Company in writing which specifies the Product to be manufactured, quantity of each Product, delivery date, or Components that will be procured by Jabil on behalf of
Customer.
		
	 “QBRs”
	  	shall have the meaning set forth in Section 7.6
		
	 “Quality Agreement”
	  	shall have the meaning set forth in Section 8.2.1
		
	 “Quality Control Procedure”
	  	shall have the meaning set forth in Section 8.2.1
		
	 “Recall”
	  	shall have the meaning set forth in Section 8.2.6
		
	 “Regulatory Approval”
	  	means, for a particular country, approval by the applicable Regulatory Authority of any and all filings required for the commercial marketing or sales of any product (or component thereof) in such country, along with satisfaction of
any related applicable regulatory requirements.

  
 Page 4 

			
	 “Regulatory Authority”
	  	means the FDA in the United States or the equivalent regulatory authority or entity having the responsibility, jurisdiction, and authority to approve the manufacture, use, importation, packaging, labeling, marketing and sale of
pharmaceutical or biological products or medical devices in any country other than the United States.
		
	 “RMA”
	  	shall have the meaning set forth in Section 5.2
		
	 “RMA Product”
	  	shall have the meaning set forth in Section 5.2
		
	 “Spares”
	  	shall have the meaning set forth in Section 4.2.2
		
	 “Specification Notice”
	  	shall have the meaning set forth in Section 4.6.
		
	 “Specifications”
	  	means the detailed description of the technical and engineering requirements for each Product, which may include dimensions, designs, procedures, parameters, processes, drawings, quality control tests, and as agreed in writing by
parties instructions relating to testing, packaging, packing and labeling of each Product that are included in a SOW, or otherwise supplied by Company and agreed upon by the Parties, and including any amendments or engineering change orders agreed
upon by Parties in writing.
		
	 “Statement of Work” or “SOW”
	  	means the statement of work for each Product set forth, a template of which is included in Schedule 1, as amended in writing from time to time upon mutual agreement of the Parties
		
	 “Termination”
	  	shall have the meaning set forth in Section 11.5.
		
	 “TSA”
	  	shall have the meaning set forth in Recital C
		
	 “Volume Pricing Matrix”
	  	shall have the meaning set forth in Section 7.1.2.1
		
	 “Warranty Period”
	  	shall have the meaning set forth in Section 5.1.
		
	 “WIP”
	  	means work in process
		
	 “Withholding Taxes”
	  	shall have the meaning set forth in Section 7.4.

 2. List of Schedules. 
  

	 	•	 	 Schedule 1: Statement of Work and/or Specifications Template 

3. Forecasts. 
 3.1.
Forecast Generation and Master Scheduling. Each month, Company shall provide a rolling [****] month forecast to Jabil as well as [****] (“Forecast”). The first [****] of the Forecast shall constitute Company’s written PO
and shall constitute a binding obligation for the Company to purchase and for Jabil to supply the amounts ordered. Company and Jabil will meet at least monthly to review the Forecast for the purpose of preparing it for Jabil’s master production
scheduling. Key data elements for the Forecast and the Master Production Schedule (as defined below) development include, but are not limited to: 
  

	 	•	 	 [****]; 

  

	 	•	 	 [****]; 

  
 Page 5 

 3.2. Master Scheduling. Jabil will develop a [****] Master Production Schedule
(“MPS”) that supports the Forecast. The proposed MPS will be based on material and capacity availability as well as the mutually agreed stock and service levels. 

3.3. Forecast Rescheduling. Any rescheduling or cancellation of the Forecast or the POs shall be subject to the terms set forth
in Section 9. 
 4. Manufacturing Services. 

4.1. Jabil’s General Obligations. Jabil will manufacture, test, pack and ship the Product in
accordance with the Specifications and any applicable Forecast and PO. Jabil will reply to each proposed PO that is submitted in accordance with the terms of this Agreement by notifying Company of its acceptance or rejection within [****] of receipt
of any proposed PO, provided that any failure to timely accept or reject any PO shall be a deemed acceptance. In the event of Jabil’s rejection of a proposed PO, Jabil’s notice of rejection will specify the basis for such rejection,
provided that Jabil shall not be entitled to reject any PO that is placed in accordance with the Forecast. Company shall be solely responsible for the sufficiency and adequacy of the Specifications. Jabil may not subcontract any of the Manufacturing
Services without Company’s prior written consent. For clarity, Component suppliers are not considered subcontractors hereunder and Jabil is permitted to have its Affiliates, and its Affiliate’s employees, perform hereunder without
obtaining Company’s prior written consent, subject to this Section 4.1. Jabil shall at all times be responsible for the compliance of its permitted subcontractors with the terms and conditions of this Agreement. Each Party may discharge
any obligations and exercise any rights hereunder through delegation of its obligations or rights to any of its Affiliates, as described above, provided that each Party hereby guarantees the performance by its Affiliates of such Party’s
obligations under this Agreement and will cause its Affiliates to comply with the provisions of this Agreement in connection with such performance and will remain ultimately responsible under this Agreement, whether or not its obligations are
performed through an Affiliate or subcontractor. 
 4.2. Consigned Equipment 

4.2.1. General Items to be Supplied by Company. Company shall supply to Jabil, according to the terms and
conditions specified herein and as applicable, Company Proprietary Information and Technology, the Loaned Equipment and Components necessary for Jabil to perform the Manufacturing Services. Company will also provide to Jabil all Specifications, Test
Procedures, Packaging and Shipping Specifications, Product design drawings, approved vendor listings, Component descriptions (including approved substitutions), manufacturing process requirements, and any other specifications necessary for Jabil to
perform the Manufacturing Services. Company shall be solely responsible for delay in delivery, defects and enforcement of warranties related to the Loaned Equipment, and Components and shall hold Jabil harmless for any claim arising therefrom, in
each case, other than to the extent caused by Jabil’s negligence, willful misconduct or breach of this Agreement. Title to the Loaned Equipment will remain with Company while in Jabil’s possession. While in Jabil’s possession, unless
otherwise set forth in the SOW, Jabil will be responsible for routine maintaining all Loaned Equipment and keeping the same in good working condition, as described in Section 4.2.2. Upon expiration or termination of this Agreement, Loaned
Equipment shall be returned to Company. 
 4.2.2. Molding and Automation Equipment; Maintenance. In order to perform
manufacturing hereunder, Company may consign molds (“Molds”) and/or automation (“Automation”) listed in a SOW for a Product that shall be used by Jabil in the manufacture of the Products. Together, the Molds and
Automation are referred to herein as the “Molding Equipment”. Within [****] days after receipt of the Molding Equipment (other than Molding Equipment procured by Jabil on Company’s behalf), Jabil will inspect and identify to
Company any deficiencies or repair requirements for such Molding Equipment. Jabil will correct any deficiencies or repair requirements that Jabil identified to Company, and Company will reimburse Jabil within [****] days of Jabil’s invoice for
any related costs incurred by Jabil in connection with those corrections. While in Jabil’s possession, unless otherwise set forth in the SOW, Jabil will be responsible for maintaining all Molding Equipment and Loaned

  
 Page 6 

 
Equipment (collectively the “Bailed Equipment”) and keeping the same in good working condition at all times. Title to the Bailed Equipment will remain with Company while in
Jabil’s possession. The Parties may agree on a maintenance plan for the Bailed Equipment, and shall include a review of the condition of the Bailed Equipment in any quarterly business review or similar meetings. Routine maintenance of the
Bailed Equipment will be carried out by Jabil. For the purpose of this Section, “routine maintenance” with respect to Molds shall mean cleaning or replacing worn or broken ejector pins and repairing any damage caused by the negligence of
Jabil and “routine maintenance” with respect to the Automation or any other Bailed Equipment shall mean such maintenance as recommended by the manufacturer or as agreed by the Parties in writing. Jabil will maintain, at Company’s
expense, a reasonable inventory of spare parts (“Spares”) for use in maintenance of the Molding Equipment. Company will issue a blanket purchase order against which Jabil will send invoices to Company for reimbursement of the cost
of the Spares and other maintenance as may be agreed. [****] will be responsible for the costs of refurbishment or replacement of the Bailed Equipment, which Jabil will undertake at a time to be determined by Jabil and Company. Refurbishment with
respect to Molds shall include, without limitation, replacing mold plates, realigning cavity pockets, repairing parting line flash, and rebuilding major components. 

4.3. Company Inspection. Company shall have the right, upon reasonable advance notice, during normal business hours and at its
expense to inspect, review, monitor and oversee the Manufacturing Services, provided that such inspection shall not disrupt Jabil’s normal business operations. Company shall cause each of its employees, agents and representatives who have
access to Jabil’s facilities, to maintain, preserve and protect all Proprietary Information and Technology of Jabil and the confidential information of Jabil’s other customers. 

4.4. Materials Procurement. Jabil will use Commercially Reasonable Efforts to procure Components [****] per Company’s
approved vendor list, that are necessary to fulfill the mutually agreed upon Product pricing, MOQs, Forecast and POs and as agreed by the Parties, with the understanding that it is the Parties’ intent that Jabil procure Components on
Company’s behalf following the validation of a sufficient credit line for Company. Notwithstanding the foregoing, the Parties understand and agree that Company may, and Company expressly reserves the right to, provide materials or Components
for use by Jabil at Jabil’s facilities, and Company shall reimburse Jabil for any reasonable and documented costs incurred by Jabil in reasonable anticipation of providing the Manufacturing Services that result from any defect of, or the
failure to provide, such materials and Components; provided that Jabil shall use Commercially Reasonable Efforts to minimize such costs. 

4.5. Materials Declaration. Where Company notifies Jabil in writing that the Product is subject to Materials Declaration
Requirements, Jabil will use Commercially Reasonable Efforts to assist Company in procuring Components that are compliant with Materials Declaration Requirements. However, Company understands and agrees that (i) Company is responsible for
notifying Jabil in writing of the specific Materials Declaration Requirements that Company determines to be applicable to the Product and shall be solely liable for the adequacy and sufficiency of such determination and information; and
(ii) any information regarding Materials Declaration Requirements compliance of Components or packaging used in the Products shall come from the relevant supplier and, without limiting any express warranty provided by Jabil hereunder, Jabil
does not test, certify or otherwise warrant Component or packaging compliance, on a homogenous material level or any other level, with Materials Declaration Requirements. 

4.6. Product Evaluation; Third Party Determination. 

4.6.1. Initial Inspection. Company shall use Commercially Reasonable Efforts to evaluate each Product to determine if it
conforms to the Product Warranty. Company shall give Jabil written notice of any rejection of a Product within [****] following Company’s receipt of such Product (“Evaluation Period”). Such written notice of rejection of a
Product for failure to conform to Product Warranty and shall include a description of Company’s basis for asserting that the Product does not conform to the Product Warranty (“Specification Notice”) Failure to provide the
Specification Notice to Jabil within the Evaluation Period shall deem the Product to be accepted. For clarity, nothing in this Section 4.6.1 shall limit in any way any ability for Company to revoke any initial acceptance or deemed acceptance or
any Product, if Company determines that any such quantity of Product delivered hereunder is Defective (defined below). 

  
 Page 7 

 4.6.2. Disputed Rejection. If Jabil disputes the basis for rejection set forth
in a Specification Notice, it shall provide written notice of the same to Company within ten (10) business days following receipt of the Specification Notice (“Notice of Disputed Defect”) and the Parties shall use good faith
efforts to resolve such as soon as practicable. If the Parties are unable to resolve such dispute within the [****] period following the delivery of the Notice of Disputed Defect, then the applicable Product shall be submitted to a mutually
acceptable Third Party that is capable of testing such Product and resolving such dispute. Such Third Party testing shall determine whether the Product is a Defective Product, and such Third Party’s determination shall be final and binding on
the Parties. The Party against whom the Third Party laboratory rules shall bear all costs of the Third Party testing. If Jabil does not dispute the basis for rejection set forth in a Specification Notice Jabil shall follow its standard return
process as set forth in Section 5.2 herein. The evaluation procedures set forth in this Section shall apply to any redelivered Product. Acceptance of Product does not waive the warranty obligations under Section 5 of this Agreement.
 
 5. Warranty & Remedy. 

5.1. Jabil Warranty. Jabil warrants to Company that (i) Jabil will manufacture the Product in accordance with a workmanship
standard mutually agreed upon in writing, if any, (ii) the Product will conform to the Specifications at the time of manufacture; (iii) the title to the tangible Products will be free and clear of any and all encumbrances, liens, or other
Third Party claims at the time of delivery that are not caused by Company’s acts or omissions; and (iv) the Products shall have been manufactured in compliance with applicable cGMP in effect at the time of manufacture of such Product
(“Product Warranty”). The above warranty with respect to any Product shall remain in effect for [****] (“Warranty Period”). This warranty is extended to [****]. Without limiting the foregoing, in the event that
Company reasonably anticipates the achievement of, or actually achieves, a validated shelf life for the Product in excess of [****], the Parties agree to negotiate in good faith an extension of the Warranty Period to align with the anticipated or
actual validated shelf life of the Product, which negotiation shall include agreement on any additional consideration payable to Jabil in consideration for such increased Warranty Period. 

5.2. Repair or Replacement of Defective Product. In accordance with Jabil’s standard return material authorization process
and procedure (“RMA”), Jabil will either repair or replace or credit [****], any Product, including a Product previously accepted by Company, that contains a defect caused by a breach of the warranty set forth in Section 5.1
provided that the Product is received by Jabil within [****] following the end of any applicable Warranty Period (“RMA Product”). Jabil will analyze any such RMA Product and, if a breach of the Product Warranty is found
(“Defect” or “Defective”), then Jabil will repair or replace the RMA Product within [****] of receipt by Jabil of the RMA Product and all required associated documentation. If Jabil determines no such Defect is
found, Parties shall follow the dispute resolution process, as outlined in Section 4.6.2. 
 5.3. Limitation of Warranty.
WITHOUT LIMITING JABIL’S INDEMNIFICATION OBLIGATIONS HEREUNDER, THE REMEDIES SET FORTH IN SECTIONS 5.1, 5.2 AND 8.2.6 SHALL CONSTITUTE COMPANY’S SOLE AND EXCLUSIVE REMEDIES WITH RESPECT TO DEFECTIVE PRODUCTS HEREUNDER. THE WARRANTY SET
FORTH IN THIS SECTION 5 IS IN LIEU OF, AND JABIL EXPRESSLY DISCLAIMS, AND COMPANY EXPRESSLY WAIVES, ALL OTHER WARRANTIES AND REPRESENTATIONS OF ANY KIND WHATSOEVER WHETHER EXPRESS, IMPLIED, STATUTORY, ARISING BY COURSE OF DEALING OR PERFORMANCE,
CUSTOM, USAGE IN THE TRADE OR OTHERWISE, INCLUDING COMPLIANCE WITH MATERIALS DECLARATION REQUIREMENTS, ANY COMPONENT WARRANTY, ANY WARRANTY OF MERCHANTABILITY, OR FITNESS FOR A PARTICULAR PURPOSE OR NONINFRINGEMENT OR MISAPPROPRIATION OF ANY RIGHT,
TITLE OR INTEREST OF COMPANY OR ANY THIRD PARTY. NO ORAL STATEMENT OR REPRESENTATION BY EITHER PARTY, ITS AGENTS OR EMPLOYEES SHALL CONSTITUTE OR CREATE A WARRANTY OR EXPAND THE SCOPE OF ANY WARRANTY HEREUNDER. 

JABIL’S WARRANTY SHALL NOT APPLY TO ANY PRODUCT THAT HAS BEEN SUBJECTED TO TESTING BY COMPANY OR ANY THIRD PARTY FOR OTHER THAN SPECIFIED ELECTRICAL
CHARACTERISTICS OR TO OPERATING AND/OR ENVIRONMENTAL CONDITIONS IN EXCESS OF THE MAXIMUM VALUES 

  
 Page 8 

 
ESTABLISHED IN APPLICABLE SPECIFICATIONS, OR TO HAVE BEEN THE SUBJECT OF MISHANDLING, ACCIDENT, MISUSE, NEGLECT, IMPROPER TESTING, IMPROPER OR UNAUTHORIZED REPAIR, ALTERATION, DAMAGE, ASSEMBLY,
PROCESSING, STORAGE OR ANY OTHER INAPPROPRIATE OR UNAUTHORIZED ACTION OR INACTION THAT ALTERS PHYSICAL OR ELECTRICAL PROPERTIES. THIS WARRANTY SHALL NOT APPLY TO ANY DEFECT IN THE PRODUCT ARISING FROM ANY DRAWING, DESIGN, SPECIFICATION, PROCESS,
TESTING OR OTHER PROCEDURE, ADJUSTMENT OR MODIFICATION SUPPLIED AND/OR REQUIRED BY COMPANY. 
 5.4. Debarment. Each Party
represents and warrants to the other Party that, to its knowledge, as of the Effective Date, it is not currently under investigation by the FDA or other Regulatory Authority for debarment or is presently debarred by the FDA or other Regulatory
Authority. If during the Term, either Party or any Person that will be involved in the performance of obligations under this Agreement (i) comes under investigation by the any Regulatory Authority for a debarment action, (ii) is debarred,
or (iii) engages in any conduct or activity that could lead to debarment, then, in each case, the Parity will immediately notify the other Party 

6. Limitation of Damages.  

EXCEPT WITH REGARD TO CONFIDENTIALITY SET FORTH IN SECTION 12 AND ANY INDEMNITIES SET FORTH IN SECTION 14 OF THIS AGREEMENT, UNDER NO CIRCUMSTANCES SHALL
EITHER PARTY BE LIABLE TO THE OTHER PARTY OR TO ANY OTHER PERSON OR ENTITY UNDER ANY CONTRACT, TORT, STRICT LIABILITY, NEGLIGENCE, OR OTHER LEGAL OR EQUITABLE CLAIM OR THEORY FOR ANY SPECIAL, INCIDENTAL, CONSEQUENTIAL, OR INDIRECT DAMAGES, LOSS OF
GOODWILL OR BUSINESS PROFITS, LOST REVENUE, WORK STOPPAGE, DATA LOSS, COMPUTER FAILURE OR MALFUNCTION, OR FOR ANY AND ALL OTHER DAMAGES, LOSS, OR EXEMPLARY OR PUNITIVE DAMAGES WHETHER SUCH PARTY WAS INFORMED OR WAS AWARE OF THE POSSIBILITY OF SUCH
LOSS OR DAMAGE. THE FOREGOING SHALL NOT EXCLUDE OR LIMIT EITHER PARTY’S LIABILITY FOR DEATH OR PERSONAL INJURY RESULTING FROM ITS NEGLIGENCE TO THE EXTENT THAT SUCH LIABILITY CANNOT BY LAW BE LIMITED OR EXCLUDED. JABIL’S AGGREGATE
LIABILITY UNDER SECTION 4.1 (JABIL GENERAL OBLIGATIONS), AND SECTION 8.2.6 (RECALLS) SHALL NOT EXCEED THE GREATER OF (A) [****] OF THE AMOUNTS PAID OR PAYABLE TO JABIL [****] FROM WHEN A CLAIM FRIST AROSE AND (B) [****]. THE LIMITATIONS SET FORTH IN
THIS AGREEMENT SHALL APPLY NOTWITHSTANDING THE FAILURE OF ESSENTIAL PURPOSE OF ANY LIMITED REMEDY STATED IN THIS AGREEMENT. 
 7. Delivery and
Financial Terms. 
 7.1. Delivery and Pricing. 

7.1.1. Delivery. Delivery shall be [****], subject to Jabil’s storage obligations as described in this Section 7.1.1.
The Parties may agree in the SOW for Jabil to segregate and store all Product until tender of delivery. Jabil shall cooperate with Company to arrange shipments for Company, including using Commercially Reasonable Efforts to secure beneficial pricing
terms for Company. If Company fails to take delivery of any Product on any scheduled delivery date, Jabil shall store (either at its facility or an approved third party facility) such Product as Company’s agent for up to [****], and Company
shall be invoiced on the first day of each month following such scheduled delivery for reasonable administration and storage costs in accordance with Jabil’s then current prices, provided that Jabil has reasonable notice of such storage request
to ensure availability of sufficient storage capacity. If need be, the Parties may agree to an extension to the storage of Products beyond the initial [****] period. For clarity, any Products that are held in storage pursuant to the foregoing are to
be held as Company-consigned inventory. 

  
 Page 9 

 7.1.2. Pricing. 

7.1.2.1. Volume Based Pricing. In the event the Prices for a Products are based on a Volume Pricing Matrix (as defined below),
this Section 7.1.2.1 shall apply; otherwise Section 7.1.2.2 shall apply. The prices for Products, and are based upon the number of units of Product purchased per Pricing Period, prorated for any partial Pricing Period, as set forth in the
volume pricing matrix initially set forth in Schedule 1 (the “Volume Pricing Matrix”). Prices for a Pricing Period will be set [****]. At the end of each quarter within a Pricing Period, Jabil will review the actual purchases of Product
during such quarter and the forecasted orders for Products in the upcoming quarter, and, if the actual purchases during the then-ending quarter and/or the upcoming quarter correspond to a different pricing band in the Volume Pricing Matrix than the
invoiced pricing band, Jabil will, within [****] after the end of the relevant quarter, either [****]; provided, however, that Jabil may adjust the pricing during a Pricing Period if the volume of Product ordered drops from the originally forecasted
amount into a lower pricing band. Invoices issued hereunder shall be subject to the payment terms herein. Jabil may adjust the Volume Pricing Matrix to reflect changes [****]. In the event of any Component pricing increases, the Volume Pricing
Matrix shall be adjusted as necessary to [****]. Further, the Volume Pricing Matrix shall be reviewed and revised on for the forth coming Pricing Period to reflect [****]. 

7.1.2.2. Standard Pricing. The following shall apply if the Prices of Products are not based on a Volume Pricing Matrix. The
Prices will be reviewed by the Parties on a quarterly basis and will be revised consistent with increases or decreases in [****] applicable to the manufacture of the Product. 

7.1.3. Export Declaration. For any shipments where Jabil acts as an agent in completing the Shipper’s Export Declaration
and managing Company’s exports on behalf of Company, where the Company is the exporter of record (Principal Party in Interest - PPI), [****]. 

7.1.4. Price Changes. In the event, at any time during performance of its obligations hereunder, Jabil’s cost of
performance significantly changes due to causes beyond its reasonable control, [****], which may be caused by [****]. Such adjustment shall be subject to the supporting documentation provided by Jabil as may be reasonably requested by Company and
shall be limited to [****] for the provision of Manufacturing Services hereunder. On a case by case basis and to the extent feasible, Jabil shall [****] the Parties agree to implement reasonable [****] price reductions in the event that
manufacturing efficiencies, supply costs or labor costs fall [****] in a manner that decreases the costs of the provision of Manufacturing Services hereunder [****]. 

  
 Page 10 

 7.2. Payment. Company shall pay Jabil all monies when due, including all NRE
Costs associated with this Agreement and agreed by the Parties in writing. Company shall make payments to Jabil upon issuance of a Purchase Order, and any amounts incurred and that are owed hereunder which are not paid upon issuance of a Purchase
Order are due [****] for undisputed amounts from the date of receipt of an invoice [****]. Company hereby [****]. Jabil may require Company or its Affiliates to provide financial assurances, such as adjusting payment terms, providing a letter of
credit or bank guarantee, or tendering a deposit if Jabil determines, in its reasonable judgment, that Company or Company’s Affiliates are not creditworthy. In the event of any late payment by Company of more than [****], monthly interest rate
of the lesser of [****], or the maximum permitted under applicable law, whichever is lower, shall accrue on the overdue amount every month past the initial invoice due date, pro rata. 

7.3. NRE. Any equipment, tooling, component, material or other goods or property, which is purchased by Jabil in order to
perform its obligations under this Agreement, shall become the property of Company once Jabil is reimbursed for all such NRE Costs. Jabil shall invoice Company for actual outstanding NRE Costs and other monies due at monthly intervals (or such other
intervals as deemed appropriate) during the term of this Agreement and upon cancellation, termination or expiration of this Agreement. Jabil agrees to request advance written approval from Company should resource requirements, and thereby NRE Costs,
increase materially relative to estimated NRE Costs initially agreed by the Parties. Upon such request, Jabil shall provide to Company reasonably detailed supporting documentation and/or descriptions of the NRE Costs for which Jabil seeks
reimbursement. 
 7.4. Taxes. Company shall be responsible for all federal, foreign, state and local sales, use, excise and
other taxes (except taxes based on Jabil’s income), all delivery, shipping, and transportation charges and all foreign agent or brokerage fees, document fees, custom charges and duties. If Company is required by law to withhold any taxes,
duties, fees, levies, or charges (“Withholding Taxes”) from any payments or reimbursements otherwise due to be paid to Jabil, Company may deduct the amount of such Withholding Taxes. Company shall promptly send Jabil original
tax receipts or other documentation evidencing the payment of such Withholding Taxes. [****]. The Parties agree to cooperate in good faith to mitigate the amount of any taxes to which either Party is subject. 

7.5. Foreign Currency. It is the intent of both Parties to trade in USD (United States dollars) whenever possible and remain
fixed in that currency unless otherwise mutually agreed otherwise. The Company and Jabil agree that there will be a currency reconciliation process. The reconciliation is the difference between the amount in USD, considering the average foreign
exchange rate in the previous month from the invoice date and the amount of USD in the payment day, according to the Wall Street Journal, each respective date; under the philosophy that no party to this agreement will benefit from currency
variation. The supplementary invoice or credit for the aforementioned reconciliation should be settled within [****]. 
 7.6.
Aggregate Credit Limit. The Parties shall agree on an aggregate level of credit that is extended to Company, which this initial amount may be adjusted from time to time as provided herein (“Aggregate Credit Limit”) and
will be subject to commercially reasonable reviews and changes as part of each of the quarterly business reviews (“QBRs”). Company’s credit level shall be reviewed in the QBRs and the Aggregate Credit Limit may be changed at
Jabil’s discretion upon review of the most recent financial statements from Company. If Company exceeds its Aggregate Credit Limit, the Parties shall immediately convene for resolution of the situation. Jabil is not obligated to extend credit
to Company beyond the Aggregate Credit Limit [****]. 

  
 Page 11 

 8. Import and Export; Quality and Regulatory Obligations; FAR Regulations. 

8.1. Import and Export. Company shall be responsible for obtaining any required import or export licenses necessary for Jabil to ship
Product, including certificates of origin, manufacturer’s affidavits, and U.S. Federal Communications Commission’s identifier, if applicable and any other licenses required under U.S. or foreign law and Company shall be the importer of
record. Company agrees that it shall not export, re-export, resell or transfer, or otherwise require Jabil to ship or deliver any Product, assembly, component or any technical data or software which violate
any export controls or limitations imposed by the United States or any other governmental authority, or to any country for which an export license or other governmental approval is required at the time of export without first obtaining all necessary
licenses and approvals and paying all duties and fees. Company shall provide Jabil with all licenses, certifications, approvals and authorizations in order to permit Jabil to comply with all import and export laws, rules and regulations for the
shipment and delivery of the Product. Company shall also be responsible for complying with any legislation or regulations governing the importation of the Product into the country of destination and for payment of any duties thereon. 

8.2. Quality and Regulatory Obligations. 

8.2.1. Quality Agreement. Upon the request of either Party following the Effective Date, the Parties shall use
Commercially Reasonable Efforts to prepare and enter into a reasonable and customary quality agreement (the “Quality Agreement”) which may include the matters referenced in other Sections of this Agreement, as well as provisions
with respect to, among other things, Specifications in respect of Product; validation; raw materials; inspection; Equipment; documentation requirements; nonconforming product and deviations from manufacturing process; nonconforming incoming
materials; yield; process validation; quality audit; records retention; design control; corrective and preventive action; and quality assurance obligations of the Parties for the Product. Upon completion and execution by the Parties, the Quality
Agreement shall be made a part of and incorporated into this Agreement. For clarity, any breach of the Quality Agreement will be deemed a breach of this Agreement. In the event of a conflict between the Quality Agreement and this Agreement,
including the terms set forth in this Section 8.2, the Quality Agreement shall govern with respect to all issues appurtenant to quality and this Agreement will govern otherwise. Without limiting the foregoing, and as set forth in additional
detail in the Quality Agreement, Jabil shall maintain and follow a quality control and testing program consistent with the Specifications and, as applicable, cGMP (the “Quality Control Procedures”). Further, the Parties shall agree
on a mutually acceptable process for qualifying new or alternate Components or suppliers of Components. To the extent that the terms or conditions of the Quality Agreement, or any procedure, specification or requirement referenced by it, conflicts
or is materially inconsistent with the terms of this Agreement, the terms of this Agreement shall prevail, other than with respect to any issue solely related to quality or quality assurance for the Products.  

8.2.2. Regulatory Activities; Information. Subject to the terms of the Quality Agreement, Jabil shall provide all regulatory and
technical information relating to the manufacture and supply of the Products as reasonably requested by Company in connection with Company’s seeking or maintaining any Regulatory Approvals, at no additional charge, including all available
information in Jabil’s control that is reasonably necessary or useful for Company to apply for, obtain and maintain Regulatory Approvals for its products that use, incorporate or are derived from any Product in any country or regulatory
jurisdiction, including, without limitation, information relating to the facilities, or the Components, process, and methodology used in the manufacture, processing or packaging of each Product and all information required to be submitted or
requested to be provided to any governmental authority in connection with the same. In addition, Jabil will reasonably cooperate with Company with respect to all reporting obligations relevant to each Product under applicable laws. 

8.2.3. Mandated Changes to Specifications and Manufacturing Process. Except as otherwise expressly set forth in the Quality
Agreement with respect to any of the following matters in this Section 8.2, the Parties agree as follows: 
 8.2.3.1. Jabil shall
obtain Company’s prior written approval, not to be unreasonably withheld, before Jabil implements any change in the Components, equipment, manufacturing process or procedures used to manufacture or test any Product in any manner that would
modify the fit, form, function, safety or efficacy of the Products manufactured hereunder. 

  
 Page 12 

 8.2.3.2. Notwithstanding the foregoing, if Jabil is required to modify the manufacturing
process for any Products to comply with changes in applicable law, then it shall immediately notify Company, and may implement such change, provided that in such case the Parties shall consult in good faith with respect to such change if such change
is reasonably likely to effect the regulatory approval for or regulatory documentation related to the Product. In the event that Jabil implements any change to the manufacturing process for any Products, then it shall maintain a device master record
of all such changes pursuant to the terms set forth in the Quality Agreement. 
 8.2.3.3. For the avoidance of doubt, Company shall have the
sole responsibility with respect to any changes to the Specifications. 
 8.2.4. Records. Jabil shall keep complete, accurate
and authentic accounts, notes, data and records pertaining to the manufacture, processing, testing and storage of each Product for at least [****] following the date of manufacture of such Product, or such longer period of time if consistent with
applicable law. During the Term, Company may periodically review, upon prior notice to Jabil, such documentation and results to audit, survey, or verify the adherence of Jabil to the Quality Control Procedures and Applicable Laws. 

8.2.5. Complaints. If either Party becomes aware of any complaint, suspected adverse research, outcome, or claim related to the
Products, then such Party shall promptly notify the other Party. If requested by Company, Jabil shall diligently conduct internal investigations, record reviews, and sample evaluations as reasonably necessary to determine the validity of any Product
complaint and Jabil shall promptly report the results to Company. 
 8.2.6. Recalls. If Company is required or requested by
any Regulatory Authority (or voluntarily decides in good faith) to recall any of Company’ products that use, incorporate or are derived from any Product, Company shall coordinate such recall. Company will notify Jabil as soon as practicable
after there is a decision by Company to institute a recall, withdrawal, or field action with respect to any Product. Jabil shall reasonably support Company’s activities associated with the recall, as requested, including but not limited to,
providing Company with the result of failure investigation associated with the recalled Product. Jabil shall contact Company for instructions with regards to validity of a request about Products or services by a Regulatory Authority. To the extent
any Defective Product results in a field alert or correction or market withdrawal within the Warranty Period (“Recall”) or a Recall is mandated, or in the opinion of Company is likely to be mandated, by the FDA under 21 C.F.R. Part
7, or any similar Regulatory Authority, for [****]. 
 8.2.7. Regulatory Actions. 

8.2.7.1. Regulatory Inspections. Jabil will permit any Regulatory Authority to conduct inspections of the Jabil facility(ies) as they
may request, including pre-approval inspections, and will reasonably cooperate with such Regulatory Authority with respect to the inspections and any related matters, in each case which is related to the
Products. If any Regulatory Authority requests access to Jabil’s quality records, facilities manufacturing the Products and/or personnel, or conducts an unannounced inspection, in each case to the extent directly concerning the Products, then
Jabil will promptly notify Company as soon as reasonably possible (in all cases within a timeframe that is set forth in the Quality Agreement or quality plan). To the extent not prohibited by law and reasonably possible, Company will have the right
to be present at any Regulatory Authority or other governmental authority inspection to the extent such inspection directly concerns the Products and, where time permits, to conduct a pre-inspection audit.
Jabil will keep Company timely informed about the results and conclusions of each regulatory inspection, including actions taken by Jabil to remedy conditions cited in the inspections. 

8.2.7.2. Information and Findings. Jabil will provide Company with copies of any written inspection reports issued by the governmental
authority and all correspondence between Jabil and the governmental authority, and all related correspondence, in each case relating to the Products or general manufacturing concerns that may be applicable to the Products (i.e., Jabil facility
compliance or the like) within [****] of Jabil’s receipt thereof. For verbal communications with a governmental authority, Jabil will provide Company with a written 

  
 Page 13 

 
summary thereof within [****] hours of such verbal communication. Where Jabil is required or intends to respond to any communication from a Regulatory Authority relating to any Products, Jabil
will provide Company with a copy of such communication and Jabil’s proposed response sufficiently in advance of the date that such response is to be submitted, in order to permit Company to review and comment upon such response. To the extent
permitted by applicable laws, Jabil will incorporate all such Company comments into such response prior to submission. Jabil will contemporaneously provide Company with a copy of any written communication from Jabil to a governmental authority
relating to any Products. 
 8.3. Design Services; US Government Contracts. In the event that the Parties agree that Jabil
will provide any technical or development services for Company, then the terms set forth in the Party’s TSA shall apply to such technical or development services. In the event that the Parties agree that Jabil will provide U.S. government
subcontract services for Company, or services related to or for export controlled products (e.g. International Traffic in Arms Regulations (ITAR) and the Export Administration Regulations (EAR) the terms and conditions of such services shall be set
forth in a separate, mutually agreed written agreement prior to the commencement of any such services. As of the effective date, neither Party believes there are any applicable FAR, DFAR, or any other FAR Supplement clauses applicable to this
Agreement. Notwithstanding the foregoing, should FAR, DFAR or any other FAR Supplemental clauses become applicable to this Agreement, then on the request of either Party, the Parties agree to negotiate an amendment to this Agreement to reflect the
application of any such clauses to the activities hereunder. If Company requires Jabil to perform any of the foregoing services prior to execution of a separate agreement, Jabil’s services will be provided “as is” and Company shall be
fully responsible for any claims or liability arising from such services and corresponding deliverables or products. 
 9. Change Orders,
Production Increases; Forecast Flexibility. 
 9.1. Specification, Product or Process Changes. Company may, in
writing, request configuration or engineering changes to Products, a change to the Manufacturing Services or Specifications at any time. Jabil will analyze the requested change and provide Company with an assessment of the effect that the requested
change will have on cost, manufacturing, scheduling, delivery and implementation. Company will be responsible for all costs associated with any accepted changes. Any such change shall be documented in a written change order and shall become
effective only upon mutual written agreement of both Parties to the terms and conditions of such change order, including changes in time required for performance, cost and applicable delivery schedules. Any resulting Excess Material and Obsolete
Material shall be subject to the terms set forth in Section 9.4. 
 9.2. Forecast/PO Flexibility. 

9.2.1. Reschedules and Cancellations. The requirements for the first [****] of the Forecast shall constitute a firm and binding
purchase order for that quantity of Products (the “Firm Period”). Pursuant to Section 4.1, Jabil shall manufacture and supply the Products in accordance with the Forecast and any applicable Firm Period and Purchase Order. The
remaining portion of the Forecast is intended to allow Jabil to purchase (and is hereby authorized to purchase) Components necessary to manufacture the quantities of Product identified, and Company shall be responsible for the cost of such
Components procured in the event of any termination or cancellation as Committed Costs. Company may request Jabil to reschedule or cancel a portion or all of the quantities within the Firm Period. Jabil may accept such requests, in its sole
discretion, and if Jabil does accept such requests, then Jabil shall provide Company a financial impact analysis on the associated costs with such reschedule or cancellation, which may include but will not be limited to [****]. Company shall pay
Jabil the costs set forth in the financial impact analysis in accordance with this Agreement. Furthermore, any quantities of Products rescheduled may not be subsequently rescheduled and reschedules of Products shall not be more than [****] from the
original delivery date. Company shall be responsible for any Excess Materials and Obsolete Material resulting from cancellations or reschedules pursuant to this Section, which shall be addressed in accordance with Section 9.4 below. 

9.2.2. Production Increases. Company may, in writing, request increases in production volume of Product for an outstanding
Forecast at any time. Jabil will analyze the request and determine if it can meet the requested increase within the required Lead-time. If Jabil can satisfy the requested increase Jabil will notify Company.

  
 Page 14 

 
If Jabil is unable to satisfy the request due to Component or capacity constraints, or other factors, Jabil will notify Company, and conduct a financial impact analysis to expedite manufacture
and delivery of the Products to meet the requested production increase as expeditiously as possible. The financial impact analysis will include, but not limited to, changes to the Product’s price, inbound/outbound shipment costs, additional
costs to supplier of Components to accelerate shipments and other material handling and/or production related charges. If the production increase is agreed upon, Company will provide a new PO setting forth the expected delivery date of the changed
order. If Jabil is unable to satisfy or comply with Company’s requested increase in production volume within the requested time frame for delivery, Jabil will provide the reasons preventing Jabil from satisfying the requested increase within
[****] after receipt of Company’s request, which could be for reasons that include capacity constraints, Component constraints, or any other factors relating to the manufacture of the Products. Any such change shall be documented in a written
change order and shall become effective only upon mutual written agreement of both Parties to the terms and conditions of such change order, including changes in time required for performance, cost and applicable delivery schedules. [****]. 

9.3. Safety Stock. Jabil and Company agree that safety stock (including components,
sub-assemblies and finished goods inventory) may be required to be held at Jabil for flexibility in certain circumstances. When appropriate, the Parties agree to establish, and Jabil agrees to hold in
inventory, safety stock at mutually agreed upon levels. Company shall be liable for safety stock mutually agreed upon and placed in inventory at Jabil. Upon mutual agreement, Company shall place a PO for the safety stock. The Parties will review
safety stock levels on at least a quarterly basis and will develop plans to resolve the issues creating the need for safety stock and remove the safety stock as soon as possible. 

9.4. Excess Material and Obsolete Material. Upon: (1) receiving notice from Company of an engineering change or
(2) any Product or Component has: (i) no PO from Company; (ii) becomes Excess Material; (iii) becomes Obsolete Material; or (iv) has reached its
end-of-life, Jabil will, within a reasonable period after receiving such notice or due to lack of POs, provide Company with an analysis of Company’s liability to
Jabil for Components acquired or scheduled to be acquired to manufacture such Product (“Material Inventory”). Company’s liability shall include [****] (“Company Liability”). Jabil will use Commercially
Reasonable Efforts to assist Company in minimizing Company Liability by taking the following steps: [****]. Upon receipt of the analysis of Company Liability, Company shall [****]. 

9.5. End of Life Material. Upon notification from Supplier of Component End-of-Life (“EOL”), Jabil will notify Company within a reasonable period after receiving such notice and provide Company with the manufacturer and the part number of such Component. Company
shall [****]. 
 10. Term. This Agreement shall be effective on the Effective Date for a period of three (3) years and shall
automatically be renewed for successive periods of one year, unless a party provides the other party with notice of its intent not to renew this Agreement at least one hundred and eighty (180) days prior to the expiration of the then current
term. Notwithstanding the foregoing, Sections 1, 2, 4.2.1 (solely with respect to return of equipment and ownership) 4.5, 4.6, 5.1, 5.2, 5.3, 6, 7, 8.1, 8.2.4, 8.2.6, 8.2.7.2 (solely with respect to any inspection that occurred prior to the
effective date of termination or expiration) 10, 11.5, 11.6, 11.7, 12, 13, 14, 15, 17, 18 and 19 herein shall survive the expiration, cancellation or termination of this Agreement. 

  
 Page 15 

 11. Termination and Termination Charges. 

11.1. Termination Rights. This Agreement may be terminated at any time upon the mutual written consent of the Parties. In
addition, this Agreement may be by either Party at will upon at least one hundred and eighty (180) days’ written notice to the other Party. 

11.2. Reserved. 

11.3. Termination for Cause. Either Party may terminate this Agreement based on the material breach by the other Party of the
terms of this Agreement, provided that the Party alleged to be in material breach receives written notice setting forth the nature of the breach at least thirty (30) days prior to the intended termination date. During such time the Party in
material breach may cure the alleged breach and if such breach is cured within such thirty (30) day period, no termination will occur and this Agreement will continue in accordance with its terms. If such breach shall not have been cured,
termination shall occur upon the termination date set forth in such notice. 
 11.4. Termination for Bankruptcy/Insolvency.
Either Party may terminate this Agreement by written notice to the other Party, effective immediately upon receipt, upon the happening of any of the following events with respect to a Party: 

11.4.1. The appointment of a receiver or custodian to take possession of any or all of the assets of the other Party, or should the
other Party make an assignment for the benefit of creditors, or should there be an attachment, execution, or other judicial seizure of all or a substantial portion of the other Party’s assets, and such attachment, execution or seizure is not
discharged within [****]. 
 11.4.2. The other Party becomes a debtor, either voluntarily or involuntarily, under Title 11 of the
United States Code or any other similar law and, in the case of an involuntary proceeding, such proceeding is not dismissed within [****] of the date of filing. 

11.4.3. The liquidation, dissolution or winding up of the other Party whether voluntarily, by operation of law or otherwise. 

11.5. Termination Effects. If this Agreement is terminated or expires for any reason, Company shall not be excused from
performing its obligations under this Agreement with respect to payment for all Committed Costs (defined below) and all monies due Jabil hereunder including costs and expenses reasonably incurred by Jabil in anticipation of the performance of its
activities under this Agreement up to and including the Termination Effective Date. Upon termination or expiration of this Agreement for any reason (“Termination”), Jabil shall [****]. All goods for which Company shall have paid
100% of Jabil’s incurred cost or more shall be held by Jabil for Company’s account and Company may arrange for its acquisition of them on AS-IS, WHERE-IS
basis. Jabil will use Commercially Reasonable Efforts to mitigate any such costs or expenses as set forth in Section 11.6 and shall provide Company with an invoice for its any costs or equipment under this Section 11.5 and any other
payments due to date prior to Termination or as soon as reasonably practicable 

  
 Page 16 

 
following Termination. To the extent that the amounts paid under any PO or work order exceed the amounts actually earned by Jabil (including committed costs as set forth above), Jabil will refund
the difference to Company within [****] of the effective date of such termination. The foregoing does not obligate Company to pay for or reimburse Jabil for the following: [****]. 

11.6. Duty to Mitigate Costs. Both Parties shall, in good faith, undertake Commercially Reasonable Efforts to mitigate the costs
of Termination. Jabil shall make Commercially Reasonable Efforts to cancel all applicable Component purchase orders and reduce Component inventory through return for credit programs or allocate such Components for alternate Company programs if
applicable, or other customer orders provided the same can be used within [****] of the termination date.  
 11.7.
Transition Support. Upon Termination, the Parties shall mutually agree on a plan to wind down or transfer the manufacturing of Products hereunder to Company or a third party (“Exit Plan”). As part of the Exit Plan, the
Parties shall agree on the commercially reasonable terms pursuant to which Jabil shall provide to Company (i) complete copies of the device master records and device history records (as stored in Jabil’s quality management system); (ii)
all Company-provided tooling, materials, Confidential Information, and Bailed Equipment in Jabil’s possession or control; (iii) any and all information that is mutually agreed upon to be reasonably necessary to enable Company to make, have
made, use, sell, offer for sale and import Products (iv) reasonable training, service, and support assistance required to enable Company to make, have made, use, sell, offer for sale and import Products; provided that generally applicable
manufacturing know-how shall not be included in the foregoing transfer unless and only to the extent necessary to make or have made the Products. Any data, know-how,
technology, or information transferred by Jabil to Company under this Section 11.7 that is Proprietary Information and Technology shall continue to be the Proprietary Information and Technology of Jabil, provided that the Parties understand and
agree that any appropriate licenses and rights of Company to use and practice such Proprietary Information and Technology of Jabil shall be set forth in Section 8.3 of the TSA (License to Jabil Technology). The reasonable out-of-pocket costs and personnel costs associated with any transfer under this Section 11.7 shall be borne by Company, provided that Jabil shall be responsible for all
internal and personnel costs incurred in connection with such transfer if such transfer is initiated following the material breach or bankruptcy of Jabil. Company reserves the right to determine at its sole discretion the manufacturer of the
Product. 
 12. Confidentiality. 

12.1. Confidentiality Obligations. In order to protect both Parties’ Proprietary Information and Technology, except as
expressly permitted under this Agreement, the Parties shall not disclose any Proprietary Information and Technology to an unauthorized third party, shall use the same degree of care, but no less than a reasonable degree of care, as such Party uses
with respect to its own similar information to protect the Proprietary Information and Technology of the other Party, and to prevent any use of Proprietary Information and Technology other than for the purposes of this Agreement. Proprietary
Information and Technology of a Disclosing Party shall not include information that the Receiving Party can demonstrate by competent written evidence: (w) is now, or hereafter becomes, through no breach of this Agreement by the Receiving Party
or any of its representatives, generally known or available; (x) is known by the Receiving Party at the time of receiving such information, as evidenced by its pre-existing written records; (y) is
hereafter furnished to the Receiving Party by a third party, as a matter of right and without restriction on disclosure; or (z) is hereafter independently developed by the Receiving Party without reference to or reliance upon Proprietary
Information and Technology and without any breach of this Agreement, as evidenced by its contemporaneously-maintained written records. For purposes of this Section 12.1, no combination of elements within the Proprietary Information and
Technology shall be deemed to be part of the public domain merely because the individual elements of such combination are part of the public domain, unless the entire combination itself, or the entire principle of use or operation of such
combination (if any), is part of the public domain. In addition, no element within the Proprietary Information and Technology shall be deemed to be a part of the public domain merely because it is embraced by more general information or data that is
part of the public domain. 
 12.2. Required Disclosures. Notwithstanding the provisions of Section 12.1, the receiving
Party may disclose Proprietary Information and Technology, without violating its obligations under this Agreement, to the extent the disclosure is required by a valid order of a court or other governmental body of competent jurisdiction or is
otherwise required by law or regulation, provided that the receiving Party shall give reasonable prior written notice to 

  
 Page 17 

 
the disclosing Party of such required disclosure and, at the disclosing Party’s request and expense, shall cooperate with the disclosing Party’s efforts to contest such requirement, to
obtain a protective order requiring that the Proprietary Information and Technology so disclosed be used only for the purposes for which the order was issued or the law or regulation required, and/or to obtain other confidential treatment of such
Proprietary Information and Technology. In any event, the receiving Party shall only disclose that portion of the Proprietary Information and Technology that is legally required to be disclosed. 

12.3. Employees, Agents and Representatives. The Receiving Party shall only permit access to Proprietary Information and
Technology to those of the Receiving Party’s employees, agents and representatives who (a) have a need to know such information, (b) have been advised by the Receiving Party of the Receiving Party’s obligations under this
Agreement, and (c) are contractually or legally bound by obligations of non-disclosure and non-use at least as stringent as those contained herein. The receiving
Party will cause each of its employees, agents and representatives to maintain and protect the confidentiality of the Proprietary Information and Technology. The failure of any employee, agent or representative of the receiving Party to comply with
the terms and conditions of this Section 12 shall be considered a breach of this Agreement by the receiving Party. 
 12.4.
Term and Enforcement. The confidentiality obligation set forth in this Agreement shall be observed during the term of the Agreement and for a period of [****] following the termination of this Agreement. Each Party acknowledges that a breach
of any of the terms of this Section 12 may cause the non-breaching Party irreparable damage, for which the award of damages would not be adequate compensation. Consequently, the non-breaching Party may institute an action to enjoin the breaching Party from any and all acts in violation of those provisions, which remedy shall be cumulative and not exclusive, and shall be in addition to any
other relief to which the non-breaching Party may be entitled at law or in equity. Such remedy shall not be subject to the arbitration provisions set forth in Section 19.10. 

12.5. Return of Proprietary Information and Technology. Upon the termination, cancellation or expiration of this Agreement, the
Receiving Party shall, upon the Disclosing Party’s written request, except to the extent Proprietary Information and Technology cannot be returned or destroyed (or deleted, in the case of information stored in computer hard drives or cloud
solutions), return all Proprietary Information and Technology (including all copies thereof) to the Disclosing Party, or at the Disclosing Party’s instruction, destroy such Proprietary Information and Technology. Any destruction of Proprietary
Information and Technology will be confirmed by the Receiving Party by means of a certificate executed by a duly authorized representative. 
 13.
Intellectual Property Rights. 
 13.1. Intellectual Property Ownership. As between the Parties, each Party shall
retain all rights, title and ownership of its own Background Intellectual Property. 
 13.2. Company Intellectual Property.
Company hereby grants to Jabil an irrevocable, perpetual, worldwide, non-exclusive, fully paid up, royalty free, non-transferable,
non-sub licensable right and license under the Intellectual Property rights owned or controlled by the Company only insofar as solely required for Jabil to perform its obligations under this Agreement. Except
expressly provided herein, neither Party grants the other Party any other rights or licenses, whether express, implied, or by virtue of estoppel or otherwise, to its Intellectual Property rights. 

13.3. Technical Services Agreement. The Parties expressly understand and agree that there shouldn’t be any Intellectual
Property newly generated under this Agreement. In the event the Parties anticipate and Created Intellectual Property (as defined in the TSA) may arise through an ECO or other engineering change, then the Parties shall develop a statement of work
under the TSA. Without limiting the foregoing, in the event that there is Created Intellectual Property generated under this Agreement that is reasonably necessary to enable Company to make, have made, use, sell, offer for sale and import Products,
the Parties expressly agree that the rights to practice such Intellectual Property shall be included in the licenses granted to the company under Section 8.3 of the TSA (License to Jabil Technology), if and as applicable. 

  
 Page 18 

 14. Company Indemnification. 

14.1. Jabil Indemnified Claims. Company shall indemnify, defend and hold harmless Jabil and its officers, directors, employees,
Subsidiaries, Affiliates, successors and assigns consultants, contractors and agents (“Jabil Indemnitees”) from and against all, damages, losses, costs and expenses, including attorneys’ fees (“Losses”), to
which any Jabil Indemnitee may become subject as a result of any third party claims, suits, actions, demands (“Claims”) asserted against Jabil to the extent such Losses arise out of: (a) the Specifications, the use of
Company’s Proprietary Information and Technology as expressly contemplated hereunder, including the use of any information, technology and processes required by Company to be used by Jabil hereunder, and the Product supplied under this
Agreement, provided that such Product was conforming Product supplied under this Agreement; (b) that any item in subsection (a) infringes or violates any patent, copyright or other intellectual property right of a third party as a result
of the use by Jabil of the foregoing as contemplated under this Agreement (and not for any combination of any such information, technology or process in connection with any Jabil technology, information or process or the manufacturing processes,
selected and utilized in the manufacture or supply of the Products hereunder); and (c) any product liability claim, including bodily injury or tangible property damage, caused by the Product supplied under this Agreement, provided that such
Product was conforming Product supplied under this Agreement; except in each case to the extent such Losses result from the breach by Jabil of any representation, warranty, covenant or agreement made by it under this Agreement or the negligence or
willful misconduct of any Jabil Indemnitee. 
 14.2. Company Indemnified Claims. Jabil shall indemnify, defend and hold
harmless Company, its Affiliates and its and their and its officers, directors, employees, consultants, contractors, (sub)licensees, and agents (“Company Indemnitees”) from and against all Losses arising from any Claims asserted
against Company Indemnitees, that arise out of: (a) any allegation that the manufacturing processes, selected and utilized in the manufacture or supply of the Products hereunder infringe or misappropriate any patent, copyright, trade secret or
other intellectual property right of a third party; and (b) any bodily injury or tangible property damage resulting from a Defect caused by the gross negligence, recklessness or willful misconduct of any Jabil Indemnitee. 

14.3. Control of Defense. In the event a party seeks indemnification under Section 14.1 or 14.2, it shall inform the other
party (the “Indemnifying Party”) of a claim as soon as reasonably practicable after it receives notice of the claim, shall permit the Indemnifying Party to assume direction and control of the defense of the claim (including the
right to settle the claim solely for monetary consideration provided that such settlement does not involve any admission wrongdoing on the part of the indemnified party), and shall cooperate as requested (at the expense of the Indemnifying Party) in
the defense of the claim. At the Indemnifying Party’s expense, the indemnified Party will provide such assistance and cooperation as is reasonably requested by the Indemnifying Party or its counsel in connection with such Claims. The
Indemnifying Party shall give the indemnified Party prompt written notice of any proposed settlement of any Claims. The Indemnifying Party shall not enter into any settlement that affects the indemnified Party’s rights or interests without
providing the indemnified Party with at least ten (10) business days’ prior written notice, and without the indemnified Party’s prior written approval, which shall not be unreasonably withheld. 

15. Relationship of Parties. Jabil shall perform its obligations hereunder as an independent contractor. Nothing contained herein shall
be construed to imply a partnership or joint venture relationship between the Parties. The Parties shall not be entitled to create any obligations on behalf of the other Party, except as expressly contemplated by this Agreement. The Parties will not
enter into any contracts with third parties in the name of the other Party without the prior written consent of the other Party. 
 16.
Insurance. Each Party will keep its business and properties insured at all times against such risks for which insurance is usually maintained by reasonably prudent Persons engaged in a similar business (including insurance for hazards
and insurance against liability on account of damage to Persons or property and insurance under all applicable workers’ compensation laws). The insurance maintained shall be in such monies and with such limits and deductibles usually carried by
Persons engaged in the same or a similar business. In support of its indemnification obligations, [****]. Nothing herein regarding insurance either limits or increases Company’s indemnification to Jabil. Certificates of Insurance shall be
provided by Company within thirty (30) days of the execution of this Agreement and annually thereafter on the anniversary date of this Agreement. Jabil shall permit Company to review its insurance status at any time by using the following
information: URL: https://aonline.aon.com; User Name: EOCJabil; Password: Cert123@. 

  
 Page 19 

 17. Publicity. Without the consent of the other Party, neither Party shall refer to
this Agreement in any publicity or advertising or disclose to any third party any of the terms of this Agreement. Notwithstanding the foregoing, neither Party will be prevented from, at any time, furnishing any information to any governmental or
regulatory authority, including the United States Securities and Exchange Commission or any other foreign stock exchange regulatory authority, that it is by law, regulation, rule or other legal process obligated to disclose, so long as the other
Party is given advance written notice of such disclosure. In addition, Company may disclose the existence and terms and conditions of this Agreement to its potential or actual investors, lenders, collaboration partners or acquirors and their
respective financial advisors and attorneys as may be necessary or useful in connection with their evaluation of such potential or actual financing, investment, collaboration or acquisition; provided, however, in each such case, on the
condition that such persons are bound by obligations of confidentiality and non-use at least as stringent as those set forth herein or that are otherwise customary for such type and scope of disclosure, and
that any such disclosure is limited to the maximum extent practicable for the particular context in which it is being disclosed. A Party may disclose the existence of this Agreement and its terms to its attorneys and accountants, suppliers,
customers and others only to the extent necessary to perform its obligations and enforce its rights hereunder. 
 18. Force Majeure.
Neither Party will be liable for any delay in performing, or for failing to perform, its obligations under this Agreement resulting from any cause beyond its reasonable control including, acts of God; blackouts; power failures; inclement weather;
fire; explosions; floods; hurricanes; typhoons; tornadoes; earthquakes; epidemics; strikes; work stoppages; labor, component or material shortages; slow-downs; industrial disputes; sabotage; accidents; destruction of production facilities; acts of
terrorism, riots or civil disturbances; acts of government or governmental agencies, including changes in law or regulations that materially and adversely impact the Party, and U.S. Government priority orders or contracts; provided that the Party
affected by such event promptly notifies [****] the other Party of the event. If the delays caused by the force majeure conditions are not cured within [****] of the force majeure event, then either Party may immediately terminate this Agreement.

 19. Miscellaneous. 

19.1. Notices. All notices, demands and other communications made hereunder shall be in writing and shall be given either by
personal delivery, by nationally recognized overnight courier (with charges prepaid), addressed to the respective Parties at the following addresses: 
  

					
	Notice to Jabil:	  	 Jabil Inc.
 10560 Dr. MLK Jr. St. N.

St. Petersburg, FL 33716
 Attn: Healthcare CEO
	  	 Notice to Company:
 Lucira
Health, Inc.,
 1412 62nd Street,

Emeryville, CA 94608

Attn: VP Global Supply Chain

			
	with a copy to:	  	 Jabil Inc.
 10560 Dr. MLK Jr. St. N.

St. Petersburg, FL 33716
 Attn: General Counsel
	  	 with a copy to:
 Lucira
Health, Inc.,
 1412 62nd Street,

Emeryville, CA 94608

Attn: Legal Department

 19.2. Amendment. No course of dealing between the Parties hereto shall be effective to amend,
modify, or change any provision of this Agreement. This Agreement may not be amended, modified, or changed in any respect except by an agreement in writing signed by the Party against whom such change is to be enforced. The Parties may, subject to
the provisions of this Section, from time to time, enter into supplemental written agreements for the purpose of adding any provisions to this Agreement or changing in any manner the rights and obligations of the Parties under this Agreement or any
Schedule hereto. Any such supplemental written agreement executed by the Parties shall be binding upon the Parties. 

  
 Page 20 

 19.3. Partial Invalidity. Whenever possible, each provision of this Agreement
shall be interpreted in such a way as to be effective and valid under applicable law. If a provision is prohibited by or invalid under applicable law, it shall be ineffective only to the extent of such prohibition or invalidity, without invalidating
the remainder of such provision or the remaining provisions of this Agreement. 
 19.4. Anti-Bribery Laws. Each Party will
perform its obligations hereunder in compliance with the United States Foreign Corrupt Practices Act (FCPA) and the UK Bribery Act. 

19.5. Entire Agreement. This Agreement, the Schedules and any addenda attached hereto or referenced herein, constitute the
complete and exclusive statement of the agreement of the Parties with respect to the subject matter of this Agreement, and replace and supersede all prior agreements and negotiations by and between the Parties. Each Party acknowledges and agrees
that no agreements, representations, warranties or collateral promises or inducements have been made by any Party to this Agreement except as expressly set forth herein or in the Schedules and any addenda attached hereto or referenced herein, and
that it has not relied upon any other agreement or document, or any verbal statement or act in executing this Agreement. These acknowledgments and agreements are contractual and not mere recitals. In the event of any inconsistency between the
provisions of this Agreement and any Schedule and any addenda attached hereto or referenced herein, the provisions of this Agreement shall prevail unless expressly stipulated otherwise, in writing executed by the Parties. Pre-printed language on each Party’s forms, including purchase orders, shall not constitute part of this Agreement and shall be deemed unenforceable. 

19.6. Assignment. This Agreement shall be binding on the Parties and their successors and assigns; provided, however, that
neither Party shall assign, delegate or transfer, in whole or in part, this Agreement or any of its rights or obligations arising hereunder without the prior written consent of the other Party. Notwithstanding the foregoing, Company may assign or
assign any or all of its rights and/or its obligations under this Agreement, without the consent of the Jabil, to an Affiliate or to any successor to all, or substantially all of its business or assets to which this Agreement relates, whether by
sale, merger, operation of law, exclusive license or otherwise. Further notwithstanding the foregoing, Jabil shall have the right to assign its rights to receive monies hereunder (but not to split such right) without the prior written consent of
Company. In any situation where consent is required, the Parties agree that such consent may be conditioned upon such terms and conditions reasonably necessary to assure the Parties of the performance of obligations owed to it under this Agreement.
Subject to the foregoing, this Agreement shall be binding upon and inure to the benefit of the Parties hereto and their respective heirs, successors and legal representatives and their respective assigns. Any purported assignment in violation of
this Section shall be null and void. 
 19.7. Waiver. Waiver by either Party of any breach of any provision of this Agreement
shall not be considered as or constitute a continuing waiver or a waiver of any other breach of the same or any other provision of this Agreement. 

19.8. Captions and Section References. The captions contained in this Agreement are inserted only as a matter of convenience or
reference and in no way define, limit, extend or describe the scope of this Agreement or the intent of any of its provisions. All references to Sections or Schedules shall be deemed to be references to Sections of this Agreement and Schedules
attached to this Agreement, except to the extent that any such reference specifically refers to another document. All references to Sections shall be deemed to also refer to all subsections of such Sections, if any. 

19.9. Construction. Since both Parties have engaged in the drafting of this Agreement, no presumption of construction against
any Party shall apply. This Agreement has been prepared in the English language and the English language shall control its interpretation. In addition, all notices required or permitted to be given hereunder, and all written, electronic, oral or
other communications between the Parties regarding this Agreement shall be in the English language. 
 19.10. Dispute
Resolution. The Parties shall use good faith efforts to resolve disputes, within [****] of notice of such dispute. Such efforts shall include escalation of such dispute to the corporate officer level of each Party. Except as set forth below, if
the Parties cannot resolve any such dispute within said [****] period, the matter shall be submitted to arbitration for resolution. Arbitration will be initiated by filing 

  
 Page 21 

 
a demand at the New York, New York regional office of the American Arbitration Association (“AAA”). Disputes will be heard and determined by a panel of three arbitrators. Each Party
will appoint one arbitrator to serve on the panel. A neutral arbitrator will be appointed by the AAA. All arbitrators must have significant experience in resolving disputes involving electronic manufacturing and design services. To the extent the
matters in dispute are provided for in whole or in part in this Agreement, the arbitrator shall be bound to follow such provisions to the extent applicable. In the absence of fraud, gross misconduct or an error in law appearing on the face of the
determination, order or award issued by the arbitrator, the written decision of the arbitrator shall be final and binding upon the Parties. Nothing contained in this Agreement shall deny either Party the right to seek injunctive or other equitable
relief from a court of competent jurisdiction in the context of a bona fide emergency or prospective irreparable harm, and such an action may be filed and maintained notwithstanding any discussions between the Parties or any arbitration proceeding.

 19.11. Other Documents. The Parties shall take all such actions and execute all such documents that may be necessary to
carry out the purposes of this Agreement, whether or not specifically provided for in this Agreement. 
 19.12. Counterparts.
This Agreement may be executed by electronic means, including Docu-sign, and delivered in one or more counterparts, each of which shall be deemed to be an original and all of which, taken together, shall be deemed to be one agreement. 

19.13. Governing Law and Jurisdiction. This Agreement and the interpretation of its terms shall be governed by the laws of the
State of Delaware, without application of conflicts of law principles. The provisions of the United Nations Convention on Contracts for the International Sale of Goods shall not apply to this Agreement. [****]. 

REMAINDER OF PAGE INTENTIONALLY LEFT BLANK 

  
 Page 22 

 IN WITNESS WHEREOF, the Parties have caused this Agreement to be executed by their duly authorized
representatives. 
  

									
	JABIL INC.	 		 	LUCIRA HEALTH, INC.
					
	By:	 	 /s/ [****]
	 		 	By:	 	 /s/ Erik T. Engelson

		 	(Signature)	 		 		 	(Signature)
					
	Name:	 	 [****]
	 		 	Name:	 	 Erik T. Engelson

		 	(Print)	 		 		 	(Print)
					
	Title:	 	 VP Global Business Units
	 		 	Title:	 	 President & CEO

					
	Date:	 	 9/16/2020
	 		 	Date:	 	 9/17/2020

  
 Page 23 

 SCHEDULE 1: STATEMENT OF WORK AND/OR SPECIFICATIONS TEMPLATE 

This Statement of Work (“SOW”) is incorporated into the Master Services Agreement (“MSA”) between Lucira Health, Inc.
(“Company”) and Jabil Inc., on behalf of itself and its Affiliates (“Jabil”) dated September 10th, 2020. The Effective Date of this SOW is [MONTH], [X] 20[X] (“SOW
Effective Date”). The term of this SOW shall commence on the Effective Date and shall continue until the work described herein has been completed or the termination of the MSA or this SOW, whichever first occurs. This SOW is governed by and
subject to the terms of the MSA. In the event of conflicts or discrepancies between the terms and conditions of the MSA and related documents including this SOW, the governing interpretations of such terms and conditions will be based on the
following order of precedence: (i) MSA; (ii) the Quality Agreement referred to in the MSA; (iii) this SOW; and (iv) other documents attached to or otherwise made part of the MSA. 

 

	1.	 Definitions 

Capitalized terms used herein shall have the same meaning as in the MSA unless otherwise specified. 

 

	2.	 Manufacturing Site 

  

	3.	 Product Lists and Initial Pricing. 

 

	4.	 Specifications/Assembly Specifications. 

 

	5.	 Test Procedures. 

  

	6.	 Packaging and Shipping Specifications. 

 

	7.	 NRE Costs (if applicable). 

 

	8.	 Components and Materials Requirements/ Bill of Material/ AVL: 

IN WITNESS WHEREOF, the Parties have caused this Agreement to be executed by their duly authorized representatives. 

 

									
	JABIL INC.	 		 	Lucira Health, Inc.
					
	By:	 	  
	 		 	By:	 	  

		 	(Signature)	 		 		 	(Signature)
					
	Name:	 	  
	 		 	Name:	 	  

		 	(Print)	 		 		 	(Print)
					
	Title:	 	  
	 		 	Title:	 	  

	Date:	 	  
	 		 	Date:	 	  

  
 Page 24EX-10.12

 CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY [****], HAS BEEN OMITTED BECAUSE IT
IS BOTH (I) NOT MATERIAL AND (II) WOULD BE COMPETITIVELY HARMFUL IF PUBLICLY DISCLOSED. 
 Exhibit 10.12 

PATENT LICENSE AGREEMENT 

THIS PATENT LICENSE AGREEMENT (this “Agreement”), dated as of this 15th day of July, 2020 (the “Effective
Date”), by and between Eiken Chemical Co., Ltd., a corporation organized and existing under the laws of Japan with its principal place of business at 19-9, Taito
4-chome, Taito-ku, Tokyo, Japan (“Eiken”) and Lucira Health, Inc., a corporation organized and existing under the laws of Delaware with its
principal place of business at 1412 62nd Street, Emeryville, CA 94608 U.S.A. (“Lucira”). 
 RECITALS

 Eiken has developed proprietary technology relating to the nucleic acid amplification referred to as “Loop-mediated
Isothermal Amplification” (the “LAMP”) and owns and has rights under certain patents and patent applications in respect of the LAMP in various countries of the world. 

Lucira wishes to obtain licenses under the LAMP Patents (as defined later) to develop, manufacture, use and sell certain products in the Field
(as defined later). 
 Eiken is willing to grant such license under the LAMP Patents under the terms and conditions hereinafter contained.

 NOW, THEREFORE, in consideration of the mutual covenants and agreements set forth herein, and for other good and valuable consideration,
the receipt and sufficiency of which are hereby acknowledged, the Parties agree as follows: 
 ARTICLE I 

DEFINITIONS; INTERPRETATION 

Section 1.01. As used in this Agreement, except as otherwise expressly provided herein or unless the
context herein otherwise requires, the following terms shall have the respective meanings indicated below: 
 “Additional
Target” has the meaning set forth in Section 2.03. 
 “Affiliate” means any corporation, company,
partnership or entity that directly or indirectly through one or more intermediaries, controls, is controlled by or is under common control with, either Party. For purposes of this definition, control means the direct or indirect legal or beneficial
ownership of greater than fifty percent (50%) of the outstanding shares of stock entitled to vote for the election of directors or persons performing similar functions, or in the case of entity not having voting stock, equivalent ownership or
interest of greater than fifty percent (50%) of its outstanding shares, or of its net asset or net profit; provided that such corporation, company, partnership or entity shall be deemed to be an Affiliate for purposes of this Agreement only
so long as such Party maintains such ownership or control. The terms “control” or “controlled by” shall have correlative meanings. 

  
 1 

 “Agreement” has the meaning set forth in the preamble hereof and
includes all Schedules, which may be amended, modified, revised or supplemented from time to time upon agreement of the Parties. 

“Arm’s Length Customer” means any customer, purchaser or third
party having no financial interest or capital investments in Lucira or any of its Affiliates sublicensed hereunder in the first bona-fide arm’s length sale from Lucira or such Affiliate of the Licensed Products to such customer, purchaser or
third party, and includes any distributor, wholesaler or other bona-fide third party purchaser of Licensed Products from Lucira or its Affiliates sublicensed hereunder. For the avoidance of doubt, the transfer or sales from Lucira to an Affiliate of
Lucira or from any of Lucira’s Affiliates to another Affiliate of Lucira shall not be considered to be sales to Arm’s Length Customer. 

“Change of Control” means at any time prior to consummation of the initial public offering of Lucira stock any
transaction or event (or series of transactions or events), whether by an acquisition of securities, merger, consolidation, proxy contest or other transaction or event (or series of transactions or events), that results in Lucira being controlled,
directly or indirectly, by a third person (whether alone or with others) that did not control Lucira before such transaction or event (or series of transactions or events), whether or not Lucira survives such transaction or event (or series of
transactions or events). For purposes of this definition, “control” means possession of, or the power or right to acquire possession of, directly or indirectly, the power to direct or cause the direction of the management, business affairs
or policies of Lucira (whether through ownership of securities, partnership or other ownership interests, by contract or otherwise). 

“Effective Date” has the meaning set forth in the preamble hereof. 

“Field” means [****]. 

“Initial Target” means severe acute respiratory syndrome coronavirus 2, SARS-CoV-2 (formerly 2019-nCoV), which causes coronavirus disease (COVID-19). 

“Interest Rate” means, with respect to any amount, the interest rate of [****] percent ([****]) per annum subject to
the maximum statutory rate of default interest permissible under applicable law. 
 “LAMP” has the meaning set forth
in the first Recital. 
 “LAMP Patents” means the patents set forth in Schedule I and any division, amendment,
inter partes review, reexamination, renewal, re-issue and extension of any of the foregoing patents. 

“License Fees” has the meaning set forth in Section 3.01. 

“Licensed Product(s)” means any reagent, product, kit, device, equipment, instrument and/or system for nucleic
acid-based in-vitro diagnostic tests for (i) the detection of a target or targets contained in the Initial Target prior to the exercise of the option set 

  
 2 

 
forth in Section 2.02 and (ii) the detection of an Additional Target or Additional Targets after the exercise of the option set forth in Section 2.04, the manufacturing, selling,
offering for sale, importing or otherwise disposing of which would constitute, but for the license herein, an infringement of any of the LAMP Patents. 

“Licensed Territory” means (i) only the United States of America under the licenses granted by Sections
2.01 and 2.03, and (ii) anywhere in the world under the licenses granted by Sections 2.02 and 2.04. 
 “Lucira
Technology” means the technology claimed in the US patents and US patent applications listed in Schedule III. 

“Net Sales” means the gross invoice price actually invoiced (or if not invoiced, the gross price actually charged) for
a Licensed Product sold by Lucira or any of its Affiliates to any Arm’s Length Customer (excluding a Licensed Product transferred, sold or otherwise disposed of by Lucira to any of its Affiliates or by any of its Affiliates to another Affiliate
thereof) minus 
  

	 	(i)	 sales tax, GST or PST, tariffs, duties, VAT, use tax, excise tax, and other governmental charges levied with
respect to the sale, transportation, delivery, use, exportation, or importation of a Licensed Product (which does not include income taxes), where such tax or other governmental charge is itemized in the invoice and actually included in such gross
invoice price or gross charge; and 

  

	 	(ii)	 [****]. 

provided, however, that (a) when a Licensed Product is used or otherwise disposed of without payment, the Net Sale of such Licensed Product shall
be [****]. 
 “Party” means either Eiken or Lucira, and “Parties” means collectively Eiken
and Lucira. 
 “Running Royalties” has the meaning set forth in Section 3.02. 

“Treaty” has the meaning set forth in Section 4.05. 

“USGAAP” means generally accepted accounting principles in the United States of America in effect at the time of
keeping the books of accounts set forth in Section 4.08. 
 Section 1.02. Interpretation 

(a) The phrase “to use the Licensed Products” means to incorporate the Licensed Products into any other products. 

(b) The term “including” means “including without limitation”. 

(c) The words “herein”, “hereof”, “hereto” and “hereunder” refer to this Agreement as a whole, and not
to any particular Article, Section or Subsection in this Agreement. 
 (d) Headings and Recitals are inserted for convenience only and do
not affect the construction hereof, words denoting the singular include the plural and vice versa, and words denoting one gender include each gender and all genders. 

  
 3 

 (e) Where an expression is defined, another part of speech or grammatical form of that
expression has a corresponding meaning. 
 (f) Unless the context otherwise requires, references herein to: 

(i) a person include references to a natural person, firm, partnership, joint venture, company, corporation, association, organization, trust,
enterprise, government or department or agency of any government (in each case whether or not having a separate legal personality); 
 (ii) a
month, quarter and year are references to a month, quarter and year of the Gregorian Calendar; 
 (iii) Recitals, Articles, Sections,
Subsection or Schedule refer to the appropriate recitals, articles, sections, subsections or schedules hereof; 
 (iv) a document, instrument
and agreement are references to such document, instrument and agreement (including schedules thereto and, where applicable, any of its provisions) as amended, modified, varied, supplemented, novated or replaced and in effect at the time any such
reference is operative; 
 (v) a Party include its permitted successors and assigns; 

(vi) a statute or law are construed as references to such statute or law as modified, amended, consolidated, extended or re-enacted and in effect at the time any such reference is operative, and include any administrative guidances, orders, regulations, instruments or other subordinate legislation made under the relevant statute or
law; and 
 (vii) an authority, association or body whether statutory or otherwise are, if and when any such authority, association or body
ceases to exist or is reconstituted, renamed or replaced or the powers or functions thereof are transferred to any other authority, association or body, references respectively to the authority, association or body established or constituted in lieu
thereof or as nearly as may be succeeding to the powers or functions thereof. 
 ARTICLE II 

GRANT OF LICENSE 

Section 2.01. Subject to the terms and conditions set forth herein, during the effective term hereof, Eiken
hereby grants to Lucira, and Lucira hereby accepts, non-transferable, non-assignable (except in connection with a permitted assignment pursuant to Section 9.01), non-exclusive license, with the right to sublicense in accordance with Section 2.05, under the LAMP Patents to develop, and make Licensed Products for the Initial Target in the Field in the United States of
America, and use, sell, offer for sale or otherwise dispose of the Licensed Products so made under Lucira’s own labels in the Field in the United States of America (the Licensed Territory). 

Section 2.02. Subject to the terms and conditions set forth herein,
Eiken hereby grants to Lucira, and Lucira hereby accepts, during the effective term hereof, an option to expand the licensed territory from the United States of America to anywhere in the world under the license set forth in Section 2.01.
Lucira may exercise the option at any time upon the payment of the fee set forth in Section 3.01(b) and a written notice to Eiken. Effective upon such exercise of the option, the license set forth in Section 2.01 shall automatically be
amended and expanded to be worldwide (the Licensed Territory). 

  
 4 

 Section 2.03.
Subject to the terms and conditions set forth herein, Eiken hereby grants to Lucira, and Lucira hereby accepts, during the effective term hereof, an option for non-transferable,
non-assignable (except in connection with a permitted assignment pursuant to Section 9.01), non-exclusive license, with the right to sublicense in accordance with
Section 2.05, under the LAMP Patents to develop and make the Licensed Products for each new additional target designated in writing by Lucira (the “Additional Target”) in the Field in the United States of America, and use, sell, offer
for sale or otherwise dispose of such Licensed Products so made under Lucira’s own labels in the Field in the United States of America. Lucira may exercise the option for each Additional Target at any time upon the payment of the fee set forth
in Section 3.01(c) and a written notice to Eiken, which notice shall contain the name of each Additional Target. Effective upon such exercise of the option with respect to each Additional Target, the foregoing license shall automatically go
into effect. 
 Section 2.04. Subject to the terms and conditions set forth herein, Eiken hereby grants to
Lucira, and Lucira hereby accepts, during the effective term hereof, an option to expand the licensed territory from the United States of America to anywhere in the world under the license set forth in Section 2.03. Lucira may exercise the
option at any time upon the payment of the fee set forth in Section 3.01(d) and a written notice to Eiken. Effective upon such exercise of the option, the license set forth in Section 2.03 shall automatically be amended and expanded to be
worldwide. 
 Section 2.05. Subject to compliance with the terms
and conditions hereof, Lucira shall have the right to grant to its Affiliates sublicenses under the license and rights granted to it hereunder but without any right to sublicense further. Lucira shall give Eiken written notice as to the names,
addresses, shareholding ratio, and any other information reasonably requested by Eiken from time to time with respect to all the Affiliates sublicensed hereunder that manufacture the Licensed Products. Each such Affiliate shall be bound by the terms
and conditions hereof as if it were named herein in the place of Lucira. The sublicense granted hereunder to an Affiliate shall automatically terminate on the date the Affiliate ceases to be an Affiliate. Lucira shall not have the right to grant a
sublicense to any person other than its Affiliates. 

Section 2.06. The license to “make” the Licensed Products
granted in Sections 2.01 and 2.03 include the right under the LAMP Patents to have a third party manufacturer designated by Lucira or its Affiliates sublicensed hereunder and approved in advance by Eiken in writing, such approval not to be
unreasonably withheld (except for the third party manufacturers set forth in Schedule IV which are hereby approved), make the Licensed Products and any component thereof either in finished or semi-finished form in accordance with the designs,
drawings and specifications and manufacturing and/or assembling drawings or specifications, all originated and owned by Lucira or such Affiliates, provided that Lucira or such Affiliates shall purchase and take over from such third party
manufacturer all of the Licensed Products manufactured and/or all portions thereof assembled by the third party manufacturer and shall not directly or indirectly re-transfer them to such third party
manufacturer or any related parties of such third party manufacturer. For the avoidance of doubt, a drop shipment of the Licensed Products by such third party manufacturer to Lucira’s or its Affiliates’ customers shall not be considered to
be in violation of this Section 2.06. 

  
 5 

 Section 2.07. Except for the licenses, options and rights
expressly granted hereunder, no right, title or interest in any discovery, invention or technology, data or information or any patent, copyright, trademark or other intellectual property right owned by Eiken or its Affiliate shall be granted to
Lucira hereunder, by implication or otherwise. Eiken shall not be under any obligation to grant to Lucira any additional licenses and rights other than those granted hereby. 

ARTICLE III 

LICENSE FEES AND ROYALTIES 

Section 3.01. In consideration of the licenses and rights granted herein, Lucira shall pay to Eiken a non-refundable license fees (the “License Fees”) as follows: 
  

	 	(a)	 with respect to the Initial Target for the license in the United States of America under Section 2.01:

  

	 	(i)	 [****], which shall be due and payable within [****] after the Effective Date; and 

 

	 	(ii)	 [****], which shall be due and payable within [****] after the Effective Date. 

 

	 	(b)	 with respect to the Initial Target for the world-wide license under
Section 2.02: 

  

	 	(i)	 [****], which shall be due and payable upon exercise of the option pursuant to Section 2.02; and

  

	 	(ii)	 [****], which shall be due and payable within [****] after exercise of the option pursuant to
Section 2.02. 

  

	 	(c)	 with respect to each Additional Target for the license in the United States of America under Section 2.03:

  

	 	(i)	 [****], which shall be due and payable upon exercise of the option for each Additional Target pursuant to
Section 2.03. 

  

	 	(d)	 with respect to each Additional Target for the world-wide license under Section 2.04:

  

	 	(i)	 [****], which shall be due and payable upon exercise of the option for each Additional Target pursuant to
Section 2.04. 

 Section 3.02. In
consideration of the licenses and rights granted herein, Lucira shall further pay to Eiken non-refundable running royalties (the “Running Royalties”) of [****] percent ([****]%) of the
total Net Sales of all the Licensed Products made, used, sold or otherwise disposed of by Lucira or any of its Affiliates in the Field in the Licensed Territory. 

Section 3.03. Running Royalties shall accrue at the time when any
Licensed Product is first sold, used or otherwise disposed of, as evidenced by the applicable invoice or bill, whether or not payment is received by Lucira or its Affiliates hereunder. No Running Royalties shall accrue at the time of the transfer,
sale or disposal of the Licensed Products by Lucira to any of its Affiliates or any of its Affiliates to another Affiliate. In such event, Running Royalties shall accrue at the time of the use, sale or disposal of the Licensed Products by such other
Affiliates to Arm’s Length Customers in the Field in the Licensed Territory. 
 Section 3.04. For the
avoidance of doubt, any portion of the License Fees paid to Eiken shall not be credited against any Running Royalties due and payable to Eiken hereunder. 

  
 6 

 ARTICLE IV 

PAYMENT AND ROYALTY REPORTS 

Section 4.01. Running Royalties accrued during each quarter (any part in the first or last quarter) during the
term of this Agreement shall be paid to Eiken or any other person designated by Eiken in writing from time to time within [****] ([****]) days after the end of such quarter. 

Section 4.02. Each Running Royalty payment shall be accompanied by a royalty report, substantially in the form
attached hereto as Schedule II covering the immediately preceding quarter showing the computation of Running Royalties for such quarter. Each royalty report shall set out by product name, model and type of each of the Licensed Products used, sold or
otherwise disposed of during the relevant quarter, the name of the manufacturer (whether Lucira or any of its Affiliates or third party manufacturers hereunder), the unit price, the quantities, the gross amount received, the relevant currency, the
deductible items set forth in the definition of the Net Sales and the total Net Sales of the Licensed Products. The royalty report shall also contain a calculation of the Running Royalties in [****] due under this Agreement and the exchange rates
used therefor. The royalty report shall be certified by an authorized officer of Lucira to be correct to the best knowledge and information of Lucira. If no Running Royalties have accrued during a quarter, the royalty report shall so state. 

Section 4.03. The License Fees, Running Royalties and any other amount payable to Eiken hereunder shall be
payable to Eiken in [****] without any deduction of any remitting bank commission or fee or otherwise at the following bank account of Eiken or any other bank account Eiken notifies Lucira in writing from time to time: 

Bank Name: [****] 
 Branch Name:
[****] 
 Bank Address: [****] 

Type of Bank Account: [****] 

SWIFT Code: [****] 
 Bank Account
Number: [****] 
 Name of the Bank Account holder: [****] 

Section 4.04. For sales of Licensed Products made in currencies other
than [****] during a quarter, Running Royalties shall be computed by converting the Net Sales into [****] at the wire transfer selling rate of exchange in effect on the closing of the last banking day during such quarter as quoted by [****]. 

Section 4.05. The Parties agree that the payments due to Eiken
hereunder constitute “royalties” as that term is defined in Article 12, paragraph 2 of the Convention between Japan and the United States of America for the Avoidance of Double Taxation and the Prevention of Fiscal Evasion with respect to
Taxes on Income and on Capital Gains (the “Treaty”) and, as such, are exempt from US withholding tax under Article 12, paragraph 1 of the Treaty. Pursuant to such exemption, Lucira shall not withhold any tax from any payments due to Eiken
hereunder, and Eiken shall not be liable for any withholding taxes involved in this transaction. Eiken shall, in addition to providing a certificate of Japanese residency, complete all forms required for Lucira to obtain such exemption and provide
Lucira with such forms. Upon Lucira’s request, Eiken shall submit a certificate of the Japanese residency, and an executed form W-8BEN-E to Lucira. 

  
 7 

 Section 4.06.
Within [****] ([****]) days after expiration or termination of this Agreement, Lucira shall furnish to Eiken a royalty report as set forth in Section 4.02 covering the Net Sales of the Licensed Products used, sold or otherwise disposed of prior
to the expiration or termination date but as to which no Running Royalties were previously paid, which report also shall set forth the total quantity of Lucira’s, its Affiliates’ and third party manufacturers’ inventory (including work-in-process) of the Licensed Products existing as of the expiration or termination date and in possession of Lucira, all of its Affiliates and third party manufacturers,
and Lucira shall simultaneously pay Running Royalties to Eiken with respect to the Licensed Products made, used or sold and inventory thereof. The Running Royalties with respect to Lucira’s, its Affiliates’ and third party
manufacturers’ inventory existing as of the expiration or termination date shall be determined as if such inventory were sold immediately prior to the expiration or termination date. 

Section 4.07. In the event that any amount due Eiken by Lucira hereunder is not paid when due, Lucira shall pay
on demand to Eiken interest on the overdue amount at the Interest Rate from the due date of such amount until the date such overdue amount is paid in full. 

Section 4.08. Lucira shall keep, and Lucira shall cause its
Affiliates to keep, accurate and complete records and books of account containing regular entries in accordance with the USGAAP consistently applied for the purpose of calculating Running Royalties and making royalty reports pursuant to
Section 4.02. All the records and books of account relating to a particular fiscal year of Lucira and such Affiliates shall be retained for a period of [****] ([****]) years following the close of such fiscal year. All records and books of
account shall contain all information necessary to calculate Running Royalties due hereunder and to determine the accuracy of the royalty reports. Eiken shall have the right (which it may not exercise more than once for each year) to cause such
records and books of account to be audited by an independent public accounting firm selected by Eiken which does not have conflicts for the sole purpose of determining the accuracy of reports and calculations of Running Royalties. Such audits shall
be made during normal business hours of Lucira or such Affiliates and with at least [****] ([****]) day prior written notice. Such audits shall not be conducted for any calendar year more than [****] years after the end of such year, or repeated for
any calendar year or with respect to the same set of records. All information disclosed to or obtained by the independent public accounting firm during such audit shall not be disclosed to anyone including Eiken (except as required by law or by any
governmental authority, and except as may be necessary in connection with any dispute resolution proceeding relating to this Agreement) and shall be held in strictest confidence, except that the independent public accounting firm may disclose to
Eiken whether a discrepancy in Running Royalty payments has been found and the amount of the discrepancy involved, and the circumstance of the discrepancy, including the basis upon which the discrepancy is determined. In the event that such audit
reveals that Lucira underpaid or under-reported Running Royalties due Eiken hereunder, Lucira shall promptly upon demand pay to Eiken the deficiency and interest thereon under Section 4.07, and if such deficiency is in excess of [****] percent
([****]%) of the amount actually due, Lucira shall also upon demand from Eiken reimburse Eiken for the costs and expenses actually incurred in conducting such audit on an indemnity basis. 

  
 8 

 Section 4.09.
Lucira shall faithfully respond with reasonable additional information to what Eiken may reasonably request from time to time to enable Eiken to ascertain a specific model or type of Licensed Products used, sold or otherwise disposed of by Lucira or
its Affiliates that is subject to the payment of Running Royalties pursuant to Section 4.01, and the amount of such Running Royalties due. 

ARTICLE V 

PATENT MARKING 
 Lucira shall mark,
and shall cause its Affiliates sublicensed hereunder to mark (i) each of the Licensed Products made, used, offered for sale or sold, (ii) its containers, and the product brochures and promotional and sales materials for the Licensed
Products, or (iii) each such Licensed Products in the form of “virtual marking” on a free-to-access web page, with the patent numbers of the LAMP Patents
utilized therefor, and shall furnish to Eiken samples of each of the Licensed Products or their containers and each copy of those product brochures and materials. 

ARTICLE VI 

GRANT BACK 
 Lucira hereby grants,
and causes its Affiliates to grant, to Eiken and its Affiliates, [****] right and license under Lucira Improvements (as defined below) to [****]. Such license includes the right for Eiken and its Affiliates to use any Lucira Improvements as part of
[****]. Promptly after Lucira becomes aware of any Lucira Improvements, Lucira shall inform Eiken thereof in writing in such reasonable manner and details as Eiken will be able to review, make further inquiries and utilize the same. For purpose of
this Agreement, “Lucira Improvements” means any discovery, invention or improvement made by or for Lucira and/or its Affiliates in the course of developing, manufacturing, using or testing the Licensed Products and any patent therefrom
owned by Lucira and/or its Affiliates, to the extent that [****]. For the avoidance of doubt, any such Lucira Improvement which [****] shall not be required to be licensed to Eiken and its Affiliates under this grant back clause, [****]. Nothing
contained herein shall be in any way construed to mean that Lucira hereby grants to Eiken licenses under the Lucira Technology which Lucira warrants and represents do not constitute any Lucira Improvements. 

ARTICLE VII 

NO WARRANTIES 

Section 7.01. Nothing in this Agreement shall be construed as: 

 

	 	(a)	 a warranty, representation or promise by Eiken relating to any of the LAMP Patents or the Licensed Products,
including the validity, scope or suitability for any purpose of the LAMP Patents; or 

  

	 	(b)	 an obligation on the part of Eiken to furnish any manufacturing or technical information to Lucira or its
Affiliates; or 

  

	 	(c)	 an obligation to bring or prosecute actions or suits against third parties, defend actions or suits brought
against Lucira, its Affiliates, their customers or third parties, or indemnify Lucira, its Affiliates, their customers or third parties for any reason; or 

  
 9 

	 	(d)	 imposing any liability on Eiken with respect to the manufacture, use, sale or disposal of the Licensed Products
by Lucira, its Affiliates, their customers or third parties; or 

  

	 	(e)	 imposing an obligation on Eiken to maintain the continued existence of any of the LAMP Patents or to file
applications for any patent or other industrial or intellectual property right or to take any action with respect to filed applications for any patent or other industrial or intellectual property rights; or 

 

	 	(f)	 conferring upon Lucira or its Affiliates the right to use in advertising, publicity or otherwise, any
trademark, service mark or trade name of Eiken, except in the case of Article V; or 

  

	 	(g)	 an obligation upon Eiken to make any determination as to the applicability of any of the LAMP Patents to any
products of Lucira or its Affiliates. 

 Section 7.02. [****]. 

Section 7.03. [****] EIKEN MAKES NO WARRANTIES, REPRESENTATIONS OR PROMISES THAT THE USE OR PRACTICE OF THE
LAMP PATENTS OR THE DEVELOPMENT, MANUFACTURE, USE, OFFER FOR SALE OR SALE OF THE LICENSED PRODUCTS DOES NOT AND WILL NOT INFRINGE ANY PATENT OR OTHER INDUSTRIAL OR INTELLECTUAL PROPERTY RIGHT OR OTHER RIGHT OWNED BY THIRD PARTIES. THE LICENSES AND
RIGHTS PROVIDED FOR HEREIN ARE GRANTED WITHOUT WARRANTIES OF ANY KIND, EITHER EXPRESS OR IMPLIED, INCLUDING THOSE OF MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. 

ARTICLE VIII 

TERM AND TERMINATION 

Section 8.01. This Agreement shall become effective on the Effective Date. 

Section 8.02. Except as otherwise provided for in this Article VIII, this Agreement, the licenses
and rights granted pursuant hereto shall remain in effect until the last to expire of the LAMP Patents. 

Section 8.03. Lucira shall have the right to terminate this Agreement at any time for any reason, upon giving
[****] days’ written notice to Eiken after Eiken has received the payments set forth in Section 3.01(a) and all the Running Royalties accrued up to the termination date, together with the royalty reports for the Running Royalties set forth
in Section 4.02. 
 Section 8.04. Eiken shall have the right forthwith to terminate this
Agreement upon written notice to Lucira in any of the following events: 
  

	 	(a)	 if Eiken has not received any Running Royalties on the Licensed Products for [****] ([****]) year after Lucira
commences the sales of the Licensed Products; 

  

	 	(b)	 if Lucira or any of its Affiliates sublicensed hereunder has defaulted in the performance or observance of any
provision, covenant, condition or agreement contained in this Agreement and has failed to cure such default within [****] ([****]) days of written notice to Lucira describing such default; 

  
 10 

	 	(c)	 if Lucira becomes insolvent or admits in writing its inability to pay its debts as the same become due or makes
an assignment for the benefit of creditors; 

  

	 	(d)	 if any proceeding is instituted by or against Lucira seeking to adjudicate it bankrupt or insolvent, or seeking
dissolution, liquidation, winding up, reorganization, arrangement, adjustment, protection, relief or composition of Lucira or its debts or seeking the entry of an order for relief or the appointment of a receiver, trustee, custodian or other similar
official for Lucira or for any substantial part of its property and assets; and 

  

	 	(e)	 if Lucira assigns or attempts to assign this Agreement or any part thereof in violation of Section 9.01.

 Section 8.05. In the event that Lucira or any of its Affiliates for itself
or through any third party files any declaratory judgment or similar action contesting the validity of any of the LAMP Patents or assists any third party in filing any such action contesting the validity of any of the LAMP Patents, to the extent
permissible by applicable law, Eiken shall have the right forthwith to terminate this Agreement or the specific licenses and rights granted hereunder in respect of such LAMP Patent upon written notice to Lucira, and the corresponding sublicenses
shall likewise terminate without any notice to its Affiliates. 
 Section 8.06. In the event that Lucira
becomes subject to a Change of Control, and unless Lucira delivers to Eiken, in writing within [****] ([****] ) days of the Change of Control, a legally binding undertaking from the third person thereafter in control of Lucira (including the entity,
if any, that ultimately controls such third person) (on behalf of itself and entities that would constitute Affiliates) to be bound by the terms and conditions of this Agreement to the same extent as if such third person (or such controlling entity)
were the party to this Agreement subject to the consent of Eiken, then Eiken shall have the right to terminate this Agreement upon written notice to Lucira, and the corresponding sublicenses shall likewise terminate without any notice to its
Affiliates. 
 Section 8.07. All licenses and rights granted to Lucira hereunder in respect of
the LAMP Patents shall cease forthwith as of the date of expiration or termination of this Agreement. In the event that this Agreement is terminated for whatever reason or expired, all the corresponding sublicenses granted to the Affiliates of
Lucira shall likewise terminate without any notice to such Affiliates. 
 Section 8.08. Any expiration
or termination of this Agreement pursuant to this Article VIII shall not relieve Lucira of any of its obligations or liabilities accrued hereunder prior to the date of expiration or termination of this Agreement, and the expiration or
termination shall not affect in any manner any rights of Eiken arising under this Agreement prior thereto. 

Section 8.09. The rights and remedies set forth in this Article VIII are not exclusive and are in
addition to any other rights and remedies available to Eiken under this Agreement or at law or in equity. 

Section 8.10. For the convenience of the Parties, this Agreement is made for patent licenses under a certain
group of patents owned by Eiken. Any judgment, adjudication, determination or order by a competent court or a regulatory authority or governmental agency which finds one or more of the LAMP Patents invalid or unenforceable shall not give rise to a
right of termination hereof or reduction of the License Fees or Running Royalties by Lucira, as long as one or more of the LAMP Patents remain valid. 

  
 11 

 Section 8.11. The provisions of Articles I, III, VI and VII
and Sections 4.02 through 4.09, 8.08, 8.09, 9.03, 9.08, 9.10, 9.11, 9.13 and 9.15 and this Section 8.11 shall survive the expiration or termination of this Agreement. 

ARTICLE IX 

MISCELLANEOUS 

Section 9.01. This Agreement and the licenses and rights granted herein shall be binding upon and inure to the
benefit of Eiken, Lucira and their respective permitted successors and assigns. Except for consummation of its initial public offering, Lucira shall not assign or transfer any of its rights, privileges or obligations hereunder without prior written
consent of Eiken. For the purpose of this Agreement, [****] any consolidation or merger by any third party with Lucira where the third party is the surviving entity or any sale of all or substantially all of the assets of Lucira relating to the
business contemplated by this Agreement to any third party shall be construed to be an assignment hereunder. [****] Any assignment or transfer in violation of this Section 9.01 shall be null and void ab initio. 

Section 9.02. This Agreement does not in any way create a relationship of principal and agent, partnership or
joint venture between the Parties. Neither Party shall under any circumstances act as, or represent itself to be, the other Party. 

Section 9.03. Any notice, report or other document required or
permitted hereunder shall be written in English, and shall be sufficiently given when personally delivered, delivered by overnight courier or mailed prepaid first class registered or certified mail and addressed to the Party for whom it is intended
at its record address set forth below, and such notice shall be effective upon receipt, if delivered personally or delivered by overnight courier, or shall be effective [****] ([****] ) days after it is deposited in the mail, if mailed. The record
addresses of the Parties are set forth below: 
  

			
	Eiken:	  	[****]
	Lucira:	  	[****]

 Either Party, at any time, may change its previous record address by giving written notice of the substitution in accordance
with the provision of this Section 9.03. 
 Section 9.04.
Whenever possible, each provision of this Agreement shall be interpreted in such manner as to be effective and valid under applicable law, but if any provision of this Agreement or portion thereof, or the application thereof to any person or
circumstance or in any country contravenes a law of any country (or political subdivision thereof) in which this Agreement is effective or is held to any extent invalid or unenforceable by a court of competent jurisdiction, the remaining provisions
of this Agreement (or of such provision) and the application thereof to other persons or circumstances or in other countries shall not be affected thereby, and this Agreement shall be modified with respect to its application in such jurisdiction,
but not in jurisdictions where such provision is valid, to conform with such law. 

  
 12 

 Section 9.05. No modification or amendment hereof shall be
valid or binding upon the Parties, unless made in writing and duly executed on behalf of the Parties by their respective duly authorized officers. 

Section 9.06. Any failure of either Party to insist upon the strict performance of any provision hereof or to
exercise any right or remedy shall not be deemed a waiver of any right or remedy with respect to any existing or subsequent breach or default. 

Section 9.07. This Agreement constitutes the entire understanding and agreement of the Parties with respect to
the subject matter hereof and supersedes all prior agreements, express or implied, and oral or written. 

Section 9.08. This Agreement shall be governed by, and shall be
construed, and the legal relations between the Parties shall be determined, in accordance with the laws of Japan without regard to what laws might otherwise govern under applicable principles of conflict or choice of laws. 

Section 9.09. This Agreement may be executed in any number of counterparts, each of which shall be deemed an
original, but all of which together shall constitute a single instrument. 
 Section 9.10. Any
dispute, controversy or difference arising out of, in relation to or in connection with, this Agreement shall be settled in good faith between the Parties. If the Parties fail to resolve such dispute, controversy or difference through the good faith
negotiations, it shall be finally settled by arbitration in Tokyo, Japan in accordance with the Rules of Arbitration of the International Chamber of Commerce for the time being in force by a panel of three (3) arbitrators. The language of the
arbitration shall be English. The prevailing Party shall be entitled to receive from the losing Party reimbursement for all costs incurred in such arbitration proceedings, including reasonable attorneys’ fees. The decision and award of the
arbitration shall be final and binding, and shall be enforceable in any court of competent jurisdiction. 

Section 9.11. The Parties shall maintain the confidentiality of the terms of this Agreement, and shall not
disclose or transfer, without the prior written consent of the other Party, such terms or any part thereof to any third party, except 
 (a)
as otherwise may be required by law, order or regulation; or 
 (b) to any competent court, regulatory authority or governmental agency
which has ordered the same to be produced; provided, however, that the Party who has been so ordered shall promptly notify the other Party of such order and use its best efforts to preserve the confidentiality thereof to the extent possible
in compliance with such order including obtaining a protective order. 
 Section 9.12. Neither
Party shall issue any press release or other public announcement relating to this Agreement without obtaining the other Party’s written approval. 

Section 9.13. The Parties hereby acknowledge that there are circumstances in which
it would be impossible to measure in money the injury that would be suffered by Eiken or Lucira, as relevant, by reason of the other Party’s breach of its obligations hereunder, and in the event that such circumstances apply, the breaching
Party consents to the granting by any court in 

  
 13 

 
any applicable jurisdiction of an injunction or other equitable relief. The foregoing shall be in addition to all other rights and remedies available to the
non-breaching Party under this Agreement or at law or in equity. 

Section 9.14. Lucira shall fully comply with all laws, ordinances and regulations applicable to it with respect
to the development, manufacture, use or sale of the Licensed Products hereunder or any other performance to be made by Lucira hereunder. 

Section 9.15. Lucira hereby agrees to defend, indemnify and hold
harmless Eiken, its Affiliates, and their respective directors, officers employees and agents from and against any and all third-party claims, actions, suits, liabilities, damages or judgments resulting from or relating to the activities of Lucira
and its Affiliates sublicensed hereunder or the manufacture, use, sale or other disposal of the Licensed Products by Lucira, its Affiliates or any other person (including third-party claims, actions, suits, liabilities, damages or judgments related
to product liability). Lucira shall assume responsibility for all costs and expenses related to any such third-party claims, actions, suits, liabilities, damages or judgments including reasonable attorneys’ fees and other litigation costs and
expenses. 
 Section 9.16. Each Party hereby represents and warrants to the other party that it has the right
and power to execute, deliver and perform this Agreement, and that its performance hereof will not result in a breach of or constitute a default under its articles of incorporation or bylaws, if any, or any contract between it and a third party.

 IN WITNESS WHEREOF, each of the Parties has caused this Agreement to be executed by its duly authorized officer as of the date and year
first above written. 
  

									
	EIKEN CHEMICAL CO., LTD.	  		  	LUCIRA HEALTH, INC.
	  
	  	            	  	  

	By:	  	[****]	  		  	By:	  	[****]
	Title:	  	[****]	  		  	Title:	  	[****]
	Date:	  		  		  	Date:	  	

  
 14 

 Schedule I 

LAMP Patents 
 [****]

  
 15 

 Schedule II 

Form of Royalty Report 

[***] 

  
 16 

 Schedule III 

Lucira Technology 

[****] 

  
 17 

 Schedule IV 

Pre-Approved third party manufacturers 

 

	 	•	 	 [****] 

  

	 	•	 	 [****] 

  

	 	•	 	 [****] 

  
 18

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00319-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00319-of-00352.parquet"}]]